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1.1 Ewing sarcoma
Ewing sarcoma (ES) is a special type of bone cancer, first described by
Dr. James Ewing in his paper ‘Diffusive endothelioma of bone’ (Ew-
ing, 1972; Appendix 1). Gathered under a common name and further
referred as Ewing sarcoma (ES for short) this group of aggressive neo-
plasms includes Ewing sarcoma of bone, extra-skeletal Ewing sarcoma,
Askin tumor and peripheral primitive neuroectodermal tumor (Delat-
tre et al., 1994; Iwamoto, 2007; Potratz et al., 2012). Today Ewing
sarcoma represents the second most common bone cancer among ado-
lescents and young adults (Delattre et al., 1994; Lamhamedi-Cherradi
et al., 2014; Ludwig, 2008). About 80% of the patients diagnosed with
Ewing sarcoma are younger then 20 years old. It is rarely diagnosed in
patients older then 30-40 years old (Iwamoto, 2007; Karosas, 2010). To
the present day the oldest patient documented case of Ewing sarcoma
belongs to a 85 years old female patient (Monument et al., 2015).
Ewing sarcoma predominantly develops in bone with the most com-
mon sites being the long bones (Fig. 1.1; Barker et al., 2005; Iwamoto,
2007; Karosas, 2010; Ludwig, 2008; Potratz et al., 2012). In soft tissues
Ewing sarcoma may develop in older patients. The earliest symptom
of ES is pain, followed by swelling and fever (Iwamoto, 2007; Karosas,
2010). Ewing sarcoma is often overlooked (Karosas, 2010; Nedelcu et
al., 2014), the diagnosis frequently is delayed by weeks and up to years
(Ludwig, 2008; Nedelcu et al., 2014). The increased time to ES diagnosis
is primarily associated with older age of patient and tumor site (Brasme
et al., 2014). Tumor sites associated with increased time to diagnosis
are skull, ribs, vertebrae, limbs, pelvis, and hand or foot (Brasme et al.,
2014). Innumerous studies together with the development of chemother-
apy (1962) and multi-modal cancer-treatment protocols increased the
5-years survival rate for Ewing sarcoma patients with localized tumor
from 10% to 70% (Iwamoto, 2007; Karosas, 2010; Lamhamedi-Cherradi
et al., 2014; Liebner, 2015; Potratz et al., 2012). Patient survival and
metastasis formation was shown to be not significantly associated with
time to diagnosis (Brasme et al., 2014). However, in more then half of
the diagnosed Ewing sarcoma cases micrometastases are presumed to
be present (Lamhamedi-Cherradi et al., 2014). Contrary to the positive
achievement in treatment of localized tumors, the long-term (5-years)
survival for Ewing sarcoma patients with metastasis, however, remain















Other bones (<1%) 
Figure 1.1
Representation of Ewing sarcoma distribution sites in human skeleton.
Potratz et al., 2012). Hence, a better understanding of the processes
underlying Ewing sarcoma metastasis deserves additional attention.
1.2 Ewing sarcoma’s origin
First Ewing sarcoma cell lines were established in 1970’s. However, of-
ten cells put in culture were initially mistakenly described as neuroblas-
toma (Schlesinger et al., 1976), rhabdomyosarcoma (Giard et al., 1973),
lymphoid cells or others. Only later characterized as Ewing sarcoma
(Martinez-Ramirez et al., 2003; Whang-Peng et al., 1986), these cells
raised a question of a common cell origin of Ewing sarcoma. There
is evidence indicating that Ewing sarcoma derives from mesenchymal
cells (Kovar, 2014; Pagani et al., 1995). Other studies show that Ew-
ing sarcoma originates from pluripotent cells with blocked differentiation
(Kovar, 2005). Lately an increasing number of reports of cellular studies
1.3 EWS/FLI fusion protein 5
suggest a neuronal origin of: CADO (Kodama et al., 1991), SS-ES-1 (Ha-
tori et al., 2006) and other cell lines (Cavazzana et al., 1987). However,
poor differentiation and the stem cell like phenotype of Ewing sarcoma
cells keep the cellular origin of Ewing sarcoma unresolved (Sand et al.,
2015). A better understanding of Ewing sarcoma origin would, hence,
potentially uncover mechanisms that control ES growth, progression and
metastasis leading to novel therapeutic strategies.
1.3 EWS/FLI fusion protein
Histologically Ewing sarcoma is identified as a small round cell tumor.
Over 90% of tumors are positive for the surface antigen MIC2 (CD99)
(Potratz et al., 2012). Cytogenetically Ewing sarcoma is characterized
by a specific chromosomal translocation t(11;22) (Aurias and Desmaze,
1992; Fraccaro et al., 1980; Iselius et al., 1983; Turc-Carel et al., 1988). In
80% of the cell lines and 90% of the primary Ewing tumors this translo-
cation is detectable (Dockhorn-Dworniczak et al., 1994). Thus, presence
of the t(11;22) translocation became the accepted hallmark in the differ-
ential diagnosis and prognosis of Ewing sarcoma (Dockhorn-Dworniczak
et al., 1994; Turc-Carel et al., 1988). There is a slight variation in break-
ing points of this reciprocal translocation. The most common, occurring
85% of the time, involve band q12 and band q24 of chromosome 22 and
chromosome 11, t(11;22)(q24;q12) (Zucman et al., 1992). Translocation
results in the expression of the fusion protein EWS-FLI-1 (Delattre et al.,
1994; Dockhorn-Dworniczak et al., 1994; Ludwig, 2008). Less common,
occurring 5-8% of the time, is the fusion protein EWS-ERG and, occur-
ring in less than 1% of the time, the fusion proteins EWS-ETV1, EWS-
EIAF, or EWS-FEV (Delattre et al., 1994; Dockhorn-Dworniczak et al.,
1994) . The fusion protein EWS/FLI-1 was shown to act as a strong
transcriptional activator (May et al., 1993; Sand et al., 2015) that inter-
feres with the expression of many genes. Key proteins of various path-
ways like IGF-1R, mTOR, MAPK, PI3K/Akt, EGFR, VEGF and others
were found to be disregulated (Ludwig, 2008). For instance, influenced
by EWS-FLI-1, the IGF-1R pathway appears to be constitutively acti-
vated in Ewing sarcoma and subsequently emerge as a key player in the
malignant transformation (Ludwig, 2008). Moreover over-expressed in
vitro or in vivo, EWS-FLI-1 promotes cell growth and facilitates suscep-
tibility to chemotherapy (Ludwig, 2008). Hence, EWS/FLI potentially
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plays a central role in Ewing sarcoma progression and metastasis.
Another evidence supporting the above conclusion is a high involve-
ment of EWS/FLI in regulation of the chemokine receptor CXCR4.
CXCR4 was shown to correlate with Ewing sarcoma metastasis (see be-
low) and poor prognosis for patients (Bennani-Baiti et al., 2010; Kim et
al., 2010).
1.4 CXCR4
In 1994 for the first time a leukocyte-derived seven-transmembrane do-
main receptor (LESTR) cDNA was isolated. The high expression of
LESTR in white blood cells was suggested to play a role in inflam-
mation. (Loetscher et al., 1994). In May 1996 using a cDNA cloning
strategy an HIV-1 cofactor was isolated, which supposedly was identi-
fied as G-protein coupled receptor with seven-transmembrane domain
structure. This cofactor was shown to promote HIV-1 fusion and virus
entry to CD4+ cells. Therefore, the protein was designated as Fusin.
(Feng et al., 1996). The discovery of Fusin was a real breakthrough in
HIV-1 research (Broder and Dimitrov, 1996; Cohen, 1996). LESTR and
Fusin happened to be the same receptor. In August 1996 the stromal-
derived factor-1 (SDF1, later designated as CXL12) has been reported
as specific chemoattractant ligand to LESTR/Fusin (Bleul et al., 1996;
Oberlin et al., 1996). Since then the previously orphan chemokine recep-
tor was designated as CXC chemokine receptor 4, short CXCR4 (Bleul et
al., 1996). SDF-1 binding to CXCR4 was shown to be a strong inhibitor
of infection by HIV-1 (Bleul et al., 1996), due to the role of the CXCR4
ligand-binding domain in HIV-1 entry (Picard et al., 1997). In 2001
the involvement of CXCR4 in breast cancer metastasis was suggested
(Muller et al., 2001). This initial association was subsequently followed
by reports, proving the role of CXCR4 in metastasis of a broad spectrum
of cancer types. Up to date, the function of CXCR4 as co-receptor for
HIV entry and its role as cancer metastasis promoter made it the best-
studied human chemokine receptor (Furusato et al., 2010). Nevertheless,
a lot of molecular details of CXCR4 function stayed yet undiscovered.
1.4.1 CXCR4 structure
The chemokine C-X-C motif receptor 4 (CXCR4) is one of ⇠20 described
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Figure 1.2
CXCR4 structure. A. A schematic representation of the structure of any G-protein
coupled receptor, consisting of an extracellular N-terminus, three extracellular loops
(EL), seven transmembrane (TM) ↵-helixes, three intracellular loops (IL), an amphi-
pathic helix H8 and an intracellular C-terminus. B. Crystal structure of chemokine
receptor CXCR4 (from Wu et al., 2010).
protein coupled receptors (GPCRs). Constituting about 800 genes of
the human genome GPCRs share a common seven-transmembrane ↵-
helix protein structure (Fig. 1.2). CXCR4 is one of the few GPCRs
and the only chemokine receptor of which the structure was successfully
resolved by X-ray crystallography (Wu et al., 2010; Fig. 1.2B). The
structure showed a remarkable resemblance with the resolved structure
of rhodopsin (Palczewski et al., 2000) and predicted earlier structures
of other GPCRs (Costanzi et al., 2009). The common structure of G-
protein coupled receptors consists of an extracellular N-terminus, three
extracellular loops (EL1-EL3), seven transmembrane ↵-helixes (TM1-
TM7), three intracellular loops (IL1-IL3), a small intracellular amphi-
pathic helix (H8) and an intracellular C-terminus (Fig. 1.2A). Some
GPCRs, e.g. CXCR4, are lacking the amphipathic helix. Each part of
GPCR has its recognized role during receptor activation (Rajagopalan
and Rajarathnam, 2006; Rosenkilde et al., 2000; Venkatakrishnan et
al., 2013). The N-terminus and the EL are responsible for specific ligand
recognition and modulation of the ligand access. The C-terminus and the
IL are responsible for modulation of receptor activity and downstream
signaling. The TM region is a communication link between extracellular
and intracellular part of the receptor.
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1.4.2 Activation mechanism
CXCR4 ligand, CXCL12, binding is a two step process. Initial inter-
action between the ligand and the N-terminus lead to conformational
changes of the receptor by which a stable interaction of the ligand with
the exposed binding pocket in CXCR4 occurs (Busillo and Benovic,
2006). Disulphide bridges in the extracellular region contribute to re-
ceptor stability (Venkatakrishnan et al., 2013). Agonist binding disrupts
the existing intramolecular interactions within CXCR4 and promotes
formation of interactions, which result in energetically favorable confor-
mational rearrangements of the receptor (Wess et al., 2008). The confor-
mational rearrangements mainly involve the transmembrane region of the
receptor and can be summarized as: (1) small local structural changes
in the TM5; (2) relocation of TM3 and TM7; (3) translation/rotation of
TM5 and TM6 (Venkatakrishnan et al., 2013). TM7 together with TM6
are bending inwards towards TM3 (Hoffmann et al., 2008) resulting in
the formation of cross-linking disulfide bonds between the cytoplasmic
ends of TM3 and TM7 (Wess et al., 2008). TM helix 6 undergoes the
largest movement (Hoffmann et al., 2008; Wess et al., 2008) resulting in
reorientation of its cytoplasmic end. It was demonstrated that the rota-
tional movement of the cytoplasmic end of TM6 (Hoffmann et al., 2008)
causes a conformational change of the third intracellular loop (Hoffmann
et al., 2008; Wess et al., 2008). The conformational change in IL3 sub-
sequently induces activation of G-protein dependent signaling pathways
(Roland et al., 2003) as the main signal transduction mechanism.
1.4.3 CXCR4 signaling
Activation of CXCR4 triggered by its specific agonist CXCL12 is a com-
plex process. Binding of CXCL12 to CXCR4 initiates receptor signaling
through four different G
↵
subunits (Rubin, 2008), resulting in PCL -,
Cdc42-, Akt-, Erk-, and Rho- dependent biochemical cascade activation.
Additionally, G-proteins independent pathways are activated, resulting
in C-terminal phosphorylation and activation of the  -arrestin pathway
leading to receptor internalization and  -arrestin signaling, respectively
(for a review see: Busillo and Benovic, 2006; Rubin, 2008; Teicher and
Fricker, 2010). The filigreed regulation and precise control over these var-
ious pathways finally result in a ligand-specific cellular reaction including
gene expression, cell proliferation, cell growth and cell migration. The
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latter is the key outcome on CXCL12-dependent chemotaxis. Chemo-
taxis, the directional cell migration in a gradient of a ligand, is refered to
as the central process during angiogenesis, embryogenesis, stem cell hom-
ing, as well as inflammation and cancer metastasis (Kryczek et al., 2007;
Teicher and Fricker, 2010). Hence, CXCR4 is recognized as a chemokine
receptor actively promoting cell migration during cancer metastasis.
1.4.4 CXCR4 in cancer metastasis
Breast, lung, ovarian, renal, prostate and other cancer cells were shown
to express high levels of CXCR4. In breast cancer (Muller et al., 2001),
prostate cancer (Wang et al., 2005), lung cancer (Phillips et al., 2003) and
others elevated CXCR4 expression has been associated with metastatic
disease and poor prognosis. Cancer cells exhibit expedited proliferation
in response to CXCL12 stimulation, while in their healthy counterparts
CXCL12-induced apoptosis was detected (Rubin, 2008). Thus, a model
was proposed, suggesting a different kinetics of the CXCR4 signaling
in cancer cells. The changed kinetics would cause overlap in G-protein
dependent and independent pathways in such a way, that it results in
the altered cellular response (Rubin, 2008).
CXCR4 was suggested to promote tumor progression by increased cell
growth, induction of angiogenesis towards the tumor tissue and formation
of metastasis (Berghuis et al., 2012; Jin et al., 2012). The interruption of
CXCL12/CXCR4 signaling was shown to inhibit the metastatic processes
(Krook et al., 2014; Muller et al., 2001; Vandercappellen et al., 2008). It
was suggested that the high level of CXCL12 expression in tissues such
as lungs, liver, lymph nodes and bone marrow defines them as main tar-
get sites for cancer metastasis driven by CXCR4 chemotaxis (Kim et al.,
2010; Raman et al., 2007; Vandercappellen et al., 2008). Hypoxia, which
typically accompanies tumor formation, was further suggested to induce
tumor-specific CXCL12 expression, which potentially initiate angiogen-
esis towards the tumor (Kryczek et al., 2007; Raman et al., 2007). At
the same time the decreased oxygen concentration within the tumor was
shown to up-regulate CXCR4 expression further promoting cell migra-
tion out of primary tumor and metastasis.
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1.5 Ewing sarcoma metastasis
Ewing sarcoma metastases occur at early stage of the tumor develop-
ment. The primary sites of metastasis are lungs, other bones and/or
the bone marrow. Metastasis to other tissues occurs in less then 1% of
all cases. (Potratz et al., 2012). Thus, Ewing sarcoma exhibits a very
unique metastasis phenotype, which is by far not well understood.
1.5.1 CXCR4 in ES metastasis
Similar to other cancer types, hypoxia results in up-regulation of CXCR4
expression in Ewing sarcoma. Additionally EWS/FLI1 result in up-
regulation of CXCR4 expression. In turn, cells overexpressing CXCR4
display an increased chemotactic migration and invasion (Krook et al.,
2014). Cell lines derived from ES patients with metastasis at diagno-
sis exhibited significantly higher expression level of CXCR4, compared
to cell lines derived from patients with solid tumor only (Bennani-Baiti
et al., 2010). The same increase of CXCR4 expression in metastasis
compared to solid tumors was shown when speciments from the patients
were analyzed (Jin et al., 2012). Thus, CXCR4 expression is corre-
lated with Ewing sarcoma progression (Berghuis et al., 2012; Jin et al.,
2012). Expression of CXCR4 in Ewing sarcoma is highly dependent
on EWS-FLI1 (Bennani-Baiti et al., 2010) and is rapidly and reversibly
modulated (Krook et al., 2014). The only other chemokine receptor
regulated by EWS-FLI1 is the orphan-receptor CXCR7. As CXCR4 it
binds to CXCL12, however CXCR7 activation is not followed by acti-
vation of G-protein signaling. Therefore, CXCR7 is considered to be a
regulatory protein for CXCR4 signaling. Evidences suggest that CXCR7
plays a role in CXCL12 scavenging (Sun et al., 2010). However, hight
CXCR7 expression in addition to high expression of CXCR4 in Ewing
sarcoma was shown to be correlated with worse patient survival prognosis
(Bennani-Baiti et al., 2010; Krook et al., 2014).
1.5.2 Other modulators of ES metastasis
Many other pathways and molecules were shown to contribute to Ewing
sarcoma metastasis regulation. Chemokine receptor CXCR6 expression
in tumor cells correlated with metastasis formation, while its ligand,
CXCL16, was associated with localization of the metastasis in lungs
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(Na et al., 2014). The orphan G-protein coupled receptor GPR64 was
shown to specifically over-express in Ewing sarcoma. GPR64 promoted
invasiveness and metastatic spread of Ewing sarcoma, while inhibition of
GPR64 resulted in a reduced colony formation in vitro, and suppressed
growth and metastasis of the tumor in vivo (Richter et al., 2013).
High levels of interleukin 6 expression in the tumor stroma of primary
ES suggest a biological relevance of this cytokine in ES pathogenesis
and, thus, mediate formation of metastases (Lissat et al., 2015). Pre-
treatment of Ewing sarcoma cells with stem cell factor (SCF) prevented
metastasis formation in lungs in mice model (Landuzzi et al., 2000).
Also metalloproteinase (MMP) 2 and 9 activity correlats with ES
cell invasion (Odri et al., 2014; Sainz-Jaspeado et al., 2010). Caveolin 1
(CAV1) involved in regulation of MMP and SPARC expression plays a
key role in ES metastasis and lung colonization (Sainz-Jaspeado et al.,
2010). Inhibition of the MMP 2 and 9 with zoledronic acid resulted in
the decrease of spontaneous lung metastases dissemination from primary
ES but not in the decrease the growth of prior lung metastases (Odri et
al., 2014).
1.5.3 Anchorage-independent growth
Hypoxia condition in the tumor tissue induces accumulation of the hy-
poxia inducible factor (HIF)-1↵ in a big fraction of primary ES (Aryee
et al., 2010). Ewing sarcoma cells adapt to hypoxia condition by mod-
ulating EWS-FLI1-dependent transcriptional signature (Aryee et al.,
2010; Krook et al., 2014). Together with other micro-environmental
stresses hypoxia promotes CXCR4-mediated Ewing sarcoma cell migra-
tion (Krook et al., 2014), invasiveness and anchorage-independent growth
(Aryee et al., 2010). In turn, an anchorage-independent growth pheno-
type was shown to predict a severe metastatic potential of primary breast
and lung tumors (Mori et al., 2009).
The adhesion of Ewing sarcoma cells is largely modulated by EWS-
FLI1 (Chaturvedi et al., 2012; Chaturvedi et al., 2014). EWS/FLI
reduce expression of zyxin and ↵5 integrin (Chaturvedi et al., 2014),
which causes the loss of organized actin stress fibers and focal adhe-
sions (Chaturvedi et al., 2012), thereby promoting the loss of the cell
spreading and enhance their capacity to grow in anchorage-independent
conditions. Ewing sarcoma cells growing in anchorage-independent con-
ditions form multicellular spheroids (Kodama et al., 1991; Landuzzi et
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al., 2000; Paszek et al., 2005). While growing in spheroids cells show
a considerably different phenotype compared to their monolayer coun-
terparts. Ewing sarcoma spheroids show reduced proliferation, highly
developed cell-cell junctions and anoikis resistance. Such phenotypic
change is a prerequisite for the successful development of metastases as
well as pronounced resistance to chemotherapy. (Strauss et al., 2010).
1.6 Cancer mechanics
1.6.1 Cellular stiffness
Besides cellular adhesion, expression of EWS/FLI largely changes the
cytoskeleton of Ewing sarcoma cells. EWS/FLI expression induces a
loss of well-defined stress fibers leading to a significant change in the
cyto-architecture on ES cells (Chaturvedi et al., 2014). A depleted actin
network was shown to be associated with a more aggressive phenotype in
colon cancer (Palmieri et al., 2015). Mechanically the weakening of the
cytoskeleton network leads to lower cell stiffness, which in turn increase
their deformability and migratory capacity (Agus et al., 2013; Katira et
al., 2013; Palmieri et al., 2015). Atomic force microscopy studies indicate
that cancer cells are softer than normal cells (Hayashi and Iwata, 2015).
Moreover, different stages of cancer can result in different changes of the
mechanical phenotype of the cells (Katira et al., 2013). Metastatic colon
cancer cells appear more modified, in terms of cell stiffness and actin
network organization, compared to the cells from the primary tumor
(Pachenari et al., 2014; Palmieri et al., 2015). The more aggressive
cancer cells exhibit a decreased viscosity (Pachenari et al., 2014) and an
increase in the non-specific adhesion toward substrates (Palmieri et al.,
2015). The adhesion capacity of the cells is primarily attained through
integrins, as integrins physically connect the cellular cytoskeleton to the
extracellular matrix (ECM). Thus, an altered expression of integrins is
thought to modulate cancer cells’ phenotype. (Jansen et al., 2015).
1.6.2 Role of the extracellular matrix
Malignant tissues dynamically remodel the extracellular matrix (ECM)
around them (Gill and West, 2014; Janmey et al., 2013; Jansen et al.,
2015; Katira et al., 2013; Tung et al., 2015). Unlike individual cells,
the overall tumor stiffness is increased compared to the normal tissue
1.6 Cancer mechanics 13
(Gill and West, 2014). This effect is reached through more dense cellu-
lar packing and an excessive production of ECM (Gill and West, 2014;
Tung et al., 2015). Increased tissue stiffness contributes to further tumor
progression and, potentially, metastasis (Janmey et al., 2013; Sapudom
et al., 2015; Tung et al., 2015). Some models suggest that the invasive
morphology of cells is promoted through an increase of the stiffness of
the cellular microenvironment (Katira et al., 2013). Mechanical stresses
regulate cellular metabolism (Tung et al., 2015) and have a pronounced
effect on cell proliferation (Janmey et al., 2013; Taloni et al., 2014). The
ECM stiffness-dependent miRNA expression is mediating malignancy of
breast epithelium (Mouw et al., 2014). Taken together, the cellular mi-
croenvironment and in particular the ECM has a significant impact on
the metastatic profile of cancer cells.
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1.7 Thesis outline
In this thesis a report on experimental work aiming for a better un-
derstanding of the mechanisms underlying Ewing sarcoma metastasis is
presented. Two distinct mechanisms are investigated: (1) a biochemical
approach in which the initial steps in the CXCR4 signaling cascade are
followed, and (2) a biophysical approach in which the guidance of EW
metastasis by the stiffness of their microenvironment is demonstrated.
In Chapter 2 the molecular mechanism of chemokine receptor
CXCR4 signaling in a model Ewing sarcoma derived cell line A673 is
studied using the single-molecule imaging technique. Effects of activation-
dependent dimerization, internalization and G-protein interaction are
tested. Measurements in resting cells and cells stimulated with CXCL12
revealed an activation-dependent mobility change of CXCR4. The mo-
bility change is shown to be associated with G protein-dependent and
independent pathways. Data indicated a functional cross-talk between
different biochemical cascades.
In Chapter 3 the regulation of CXCR4 signaling in Ewing sarcoma
is further addressed by investigation of the receptor interaction with the
respective G-proteins. Two different G
↵
-subunits exhibited a differen-





interact with the receptor in a sequential manner. The sequential
receptor/G-protein interaction was correlated with the timing of the fol-
lowing signaling cascades, which might reflect a potential mechanism for
pathway-specific signal regulation.
In Chapter 4 a newly emerging approach of optogenetics was ex-
ploited to develop an all optically-controlled chimeric receptor
optoCXCR4. A detailed description of the design of a chimeric receptor
is present together with various experiments to test for proper function-
ality. The developed construct represents a promising tool for further
biophysical investigation of chemokine receptor CXCR4 signaling, that
permits external cellular control at high temporal and spatial resolution.
In Chapter 5 a hypothesis of the mechanical guidance of Ewing sar-
coma metastasis was examined. The influence of the mechanical prop-
erties of the microenvironment on ES was tested in 2D and 3D assays.
Various Ewing sarcoma derived cells exhibited an evident difference in
mechanical phenotype depending on their metastatic niche. The softer
microenvironment appeared more attractive for cells derived from pa-
tients with lungs metastasis localisation, while stiffer substrates resulted
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in higher adhesion potential for cells derived from patients bone metas-
tasis localization. Notably, activation of the CXCR4 receptor had no
evident effect on the mechanical phenotype.
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1.8 Appendix
The history of Ewing sarcoma starts in 1920’s, when the pathologist J.
Ewing published his first work on a new kind of bone cancer.
James Ewing, born in 1866, graduated from Columbia University
College of Physicians and Surgeons in 1891. In 1899 Ewing became the
first professor of pathology at Cornell University Medical College (Huvos,
1998). In 1913 Ewing became the first Director of Pathology at present-
day Memorial Sloan-Kettering Cancer Center in New York City (then
called New York Cancer Hospital) (Huvos, 1998; www.mskcc.org). In
1931, after his retirement from Cornell as Chairman of the Department of
Pathology, Ewing became the Director of Memorial Hospital for Cancer
and Allied Diseases (Huvos, 1998).
At the time Ewing was one of the central figures in many aspects
of cancer-related research and owned to be named “Cancer Man” by the
Times Magazine (Fig. A1) (www.time.com). His work was considered as
an excellent starting point for any aspect of oncology (Shimkin, 1974).
Under J. Ewing guidance the New York Cancer Hospital became world-
wide recognized in the diagnosis and management of neoplastic diseases
(www.mskcc.org). He was a ‘father’ of the American Society of the Can-
cer Control (A.S.C.C., 1913) (Triolo and Shimkin, 1969), and President
of the American Association for Cancer Research (AACR) in 1907-09
(Triolo and Riegel, 1961). As member of the AACR Ewing was involved
in the establishment of Journal of Cancer Research (Cancer Research at
present-day) in 1916, and its reformation into the American Journal of
Cancer in 1930 (Triolo and Riegel, 1961).
In 1919 the first edition of Ewing book ‘Neoplastic Diseases: A Text-
Book on Tumors’ was published (Ewing, 1922). The book gave a compre-
hensive overview and classification of the available studies on neoplastic
diseases (Ewing, 1922; Huvos, 1998) and provided a systematic basis for
diagnosing human cancer, representing a keystone of modern oncology
(www.mskcc.org). Already in 1922 the second edition of the book was
published. It included studies collected over the past two years, new
microphotographs and a major correction on ‘Tumor of bone’ chapter
(Ewing, 1922). In his book (and lectures) Ewing described a special
case of a 14-year-old girl patient with a large tumor of the ulna (Ew-
ing, 1922; Huvos, 1998). The most abundant treatment at the time was
amputation. However, given his personal history of facing a potential




his patient. A treatment with only x-ray irradiation was used instead.
The treatment resulted in disappearance of the tumor (Huvos, 1998).
Together with multiple similar cases, this observation and collaborative
work with Dr. Douglas lead to foundation of a radium department in
the New York Cancer Hospital in 1915, and thus gave birth to radiation
therapy in the United States (www.mskcc.org; Huvos, 1998).
Ewing noticed, that radiosensitivity was shared by a specific type of
bone sarcoma, characterized by the typical microscopic appearance and
known as round cell sarcoma. He described his observations and the
14-year-old girl case in his first publication on a new kind of malignant
osteoma - ‘diffuse endothelioma of bone’ in 1921 (Choudhury et al., 2011;
Ewing, 1972; Huvos, 1998). This is were the origin of the long history of
Ewing sarcoma takes its start.
By 1927 there were more case reports with symptoms similar to the
‘new’ bone cancer. Representing 7% of the total bone cancer reports at
the time, it was appointed the name ‘Ewing sarcoma’ (Pritchard, 1927).
Extensive research and development in cytogenetics resulted in the es-
tablishment of the common chromosomal translocation which became
characteristic to Ewing sarcoma in 1980’s (Fraccaro et al., 1980; et al.,
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1983; Turc-Carel et al., 1988). Around 1987 the break points of recip-
rocal translocation at 11q24 and 22q12 were confirmed to be uniform
for Ewing sarcoma. In 1994 the resulting fusion-protein was identified
(Delattre et al., 1994). From then on the presence of the fusion-proteins
EWS/FLI or EWS/ERG became a defining criterion for Ewing sarcoma
(Delattre et al., 1994).
Today Ewing sarcoma is the second most common bone cancer in chil-
dren and young adults. The average patients age is 13 years with a range
from 1 to 48 years. It is described as small-round cell tumor and identi-
fied by molecular genetic analysis for the t(11,22)q(24;12) translocation
and the expression of EWS/FLI or EWS-ERG. (Delattre et al., 1994;
Dockhorn-Dworniczak et al., 1994; Ludwig, 2008; Sand et al., 2015).
Ewing worked through his life to better understand and search ways
to fight the disease of cancer. He made a huge impact, particularly on the
cancer of bone. Through almost 100 years Ewing sarcoma still holds the
name of a great pathologist and oncologist of early 20th century James
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CXCR4 signaling is controlled
by immobilization at the
plasma membrane1
1This chapter is based on: E. Beletkaia, S. F. Fenz, W. Pomp, E. Snaar-Jagalska,
P. W. C. Hogendoorn, T. Schmidt, CXCR4 signaling is controlled by immobilization
at the plasma membrane (under review at BBA - Molecular cell research)
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Understanding of the regulation mechanisms of CXCR4 signaling is
essential for revealing its role in physiological and pathological processes.
Though biochemical pathways following CXCR4 activation by its ligand
CXCL12 are well established, knowledge about the receptor dynamics on
the plasma membrane remains limited. Here we used Ewing sarcoma-
derived cells to unravel the processes that are involved in regulating
CXCR4 dynamics on the plasma membrane during receptor signaling.
Single-molecule epi-fluorescence microscopy showed that CXCR4 was
present in monomeric state on the plasma membrane independent of re-
ceptor stimulation. However, upon activation freely diffusing receptors
were immobilized in a ligand concentration-dependent manner. CXCR4
immobilization was strongly correlated with the ability for G-protein sig-
naling and was a precursor of subsequent endocytotic events. We found
that a balanced regulation of G-protein dependent and independent path-
ways was required for faithful receptor signal transduction.
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2.1 Introduction
Ewing sarcoma is a high-grade aggressive tumor occurring predomi-
nantly in bones of young children and adolescent. About a quarter
of Ewing sarcoma patients have developed metastasis present at first
diagnosis (Kovar, 2014). The characteristic and most common chromo-
somal translocation fusing a portion of the EWSR1 gene to the FLI
gene, t(11;22)(q24;q12), results in the chimeric protein, EWS/FLI. This
translocation was shown to change the expression of many different
genes (Kovar, 2014). Frequently over-expressed in Ewing sarcoma is
the chemokine receptor/ligand CXCR4/CXCL12 axis was suggested to
promote tumor progression and cell growth (Berghuis et al. 2012). Addi-
tionally, CXCR4 was shown to be associated with Ewing sarcoma metas-
tasis and with a poor prognosis for patients (Kim et al., 2011; Bennani-
Baiti et al., 2010). Thus, understanding of the molecular mechanisms of
CXCR4 signaling regulation is essential.
The C-X-C chemokine receptor type 4 (CXCR4) belongs to the class
of G-protein coupled receptor (GPCRs). CXCR4 selectively binds to
the C-X-C chemokine CXCL12. The CXCR4/CXCL12 pathway is bio-
chemically well studied (Teicher and Fricker, 2010). Binding of CXCL12
causes conformational changes of the receptor and promotes activation





-subunits leads to initiation of the respective pathways downstream
of CXCR4. CXCR4 activates four different G
↵
subunits (Rubin, 2009)




(Teicher and Fricker, 2010).
Activation of G
↵q
regulates protein kinase C (PKC) signaling that leads
to Ca2+ release. The G
↵i
-pathway involves activation of Akt, Erk1/2
and Cdc42 cascades. Dissociated G
  
activates phospholipase-C (PLC)
and phosphoinositide-3 kinase (PI3K). The ultimate outcome of CXCR4
signaling leads to gene transcription, cell adhesion and cell migration
(Busillo and Benovic, 2007; Otsuka and Bebb, 2008; Teicher and Fricker,
2010) and hence can be involved in tumor, e.g. Ewing sarcoma, progres-
sion and metastasis.
Frequently GPCR signaling is controlled via receptor dimerization.
There is evidence that CXCL12-induced activation of CXCR4 leads to
the formation of heterodimers with CCR2 and CXCR7 (Springael et al.,
2005; Levoye et al.,2009; Luker et al., 2009; Decaillot et al., 2011). It was
shown that CXCR7 can regulate CXCR4-dependent pathways by pro-
moting or inhibiting G-protein activation (Levoye et al.,2009; Decaillot et
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al., 2011), or act as a CXCL12 scavenger (Naumann et al., 2010). How-
ever, some Ewing sarcoma cells, including cell line A673, do not express
CXCR7 nor CCR2 (Bennani-Baiti et al., 2010),thus, heterodimerization
of CXCR4 with these receptors is likely unimportant.
Many GPCRs are in a dynamic equilibrium between monomers and
homo-dimers on the plasma membrane (Kasai and Kusumi, 2014). BRET
experiments imply that a small portion of CXCR4 forms homodimers
even in the absence of CXCL12 (Hamatake et al., 2009). Additionally,
the CXCR4 crystal structure suggests homodimeric state of CXCR4 (Wu
et al., 2010). Some studies report that stimulation with CXCL12 is re-
quired for CXCR4 homodimerization (Springael et al., 2005), while oth-
ers report no dimerization of CXCR4 upon activation (Hamatake et al.,
2009).
Alongside with receptor dimerization, internalization of GPCRs is
considered a regulatory process. Upon activation CXCR4 promotes  -
arrestin recruitment that subsequently leads to receptor internalization.
Internalized receptors in turn can be recycled to the plasma membrane
or follow the lysosomal path towards breakdown (Busillo and Benovic,
2007). This process is recognized as receptor desensitization. In Ewing
sarcoma endocytosis was identified to have a strong impact on receptor
signaling (Martins et al., 2011).
Thus, CXCR4 conduct on the plasma membrane is very dynamic and
has great impact on the receptor signaling. However, knowledge about
CXCR4 dynamics on the plasma membrane is controversial. Hence, we
decided to use the high spatial and temporal resolution that is combined
in single-molecule microscopy to obtain novel understanding of CXCR4
signaling. In the last decade a number of single-molecule studies were
undertaken to study receptor dynamics on the plasma membrane and
relate the findings to the signaling outcome (de Keijzer et al., 2008;
Ueda et al. 2001; Jacquier et al., 2006; Calebiro et al., 2013; Lill et al.,
2005; Ye et al., 2013). Here we investigated the membrane dynamics of
CXCR4-eYFP in the Ewing sarcoma derived cell line A673. We observed
a correlation between receptor stimulation and mobility. Immobilization
of the activated receptor was facilitated via G
↵i
mediated pathway and
clathrin-dependent endocytosis. Thus, we found indications that recep-
tor signaling was controlled via a regulatory cross-talk between G-protein
dependent and independent pathways.
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2.2 Materials and Methods
2.2.1 Cell culture and transfection
A673 cells were maintained in IMDM cell culture medium (Gibco, USA)
supplemented with 10% fetal bovine serum (FBS, Gibco, USA) at 37 C
and 5% CO2. To study the CXCR4 receptor, A673 wild type (A673
wt) cells were stably transfected using a retroviral construct encoding
for CXCR4-eYFP (kindly provided by Prof. Dr. Nikolaus Heveker,
University of Montreal). Viral transfection was performed as follows.
5⇥ 104 cells/well were seeded in a 24-well plate; the next day, 1 MOI of
viral particles and 5 µg/mL polybreen was added for 24 hours, followed
by medium refreshment. For experiments A673 cells stably transfected
with CXCR4-eYFP (further referred to as A673-CXCR4 cells) were used
after three passages.
2.2.2 Sample preparation
For imaging 1x105 of A673-CXCR4 cells were placed in 0.35 mm culture
dishes (Ibidi, Germany) in 2 mL of complete IMDM medium (with 10%
FBS) and left to attach overnight. Before imaging the medium in the
samples was replaced with fresh IMDM without serum to minimize aut-
ofluorescence. During imaging the CO2 level was maintained at 5% and
temperature at 37 C using the INUBG2E-ZILCS (TokaiHit, Japan).
2.2.3 Global CXCL12 stimulation assay
Activation of the CXCR4 receptor with its specific ligand, CXCL12
(Gibco, USA) was done as global stimulation before imaging: CXCL12
was added to the medium to a final concentration of 6-200 nM. Single-
molecule or confocal imaging was performed within 1 hour after addition
of CXCL12.
2.2.4 Calcium assay
The change of the cytoplasmic Ca2+ concentration was measured us-
ing cell-permeant Fluo4-AM (Invitrogen, USA). Cells were supplemented
with 10 µM Fluo4-AM for 30 minutes; prior to imaging the medium in the
samples was replaced with fresh IMDM without serum to remove Fluo4-
AM from the cells environment. Using time-lapse confocal microscopy
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(see below) the Fluo4-AM fluorescence was detected in individual cells
with 50 ms laser pulses at 488 nm. Time-lapse imaging of the cells was
done with a 100⇥ objective at 5 Hz for 5 minutes. Where indicated,
imaging was done with a 10⇥ objective and the fluorescence change was
determined for the whole field of view. At a specified time point 100
nM CXCL12 was added and the change in fluorescence intensity inside
individual cells was registered.
2.2.5 Actin depolymerization
To induce cytoskeletal actin depolymerization cells were pre-incubated
with 500 nM latrunculin B (LatB; Sigma, USA) for 30 minutes, which
was sufficient for temporal actin cytoskeleton depletion. Subsequently
cells were washed with fresh medium and imaged in serum free IMDM
with or without global stimulation. Imaging was performed in a 30
minutes time window after medium change. The actin cytoskeleton was
repolymerized within that time (Fig. S1).
2.2.6 Endocytosis inhibition
Endocytosis inhibition was achieved by addition of 25 µM chlorpro-
mazine (CHZ; Sigma, USA), to the cells for 30 min prior to imag-
ing. For imaging the medium was replaced by serum free IMDM and





Pertussis toxin (PTX; Sigma, USA) was used to detach G
↵i
from CXCR4.
A673-CXCR4 cells were pre-incubated with 200 ng/mL PTX for 5 hours
and then single-molecule imaging was done in presence of PTX in the
serum free IMDM medium with or without global stimulation.
2.2.8 Single-molecule imaging
For single-molecule imaging we combined wide-field microscopy with
high-sensitivity fluorescence microscopy as described in detail earlier
(Schmidt et al., 1996). In brief, the sample was mounted onto an in-
verted microscope (Zeiss, Germany) equipped with a 100⇥ objective
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(NA=1.4, Zeiss) and a liquid nitrogen-cooled back-illuminated CCD-
camera (Princeton Instruments, USA). A region of interest was set to
40⇥40 pixels with an apparent pixel size of 202±2 nm. Measurements
were done by illumination of the sample with a 514 nm laser beam
(Coherent, Germany) for 5 ms at the intensity of 2 kW/cm2. 1500
images were recorded at 20 Hz. Use of the appropriate filter combi-
nation: dichroic: z405/514/647/1064rpc and emission filter: z514/647m
(Chroma, USA) permitted the signal detection by the CCD-camera. The
x/y positions of individual molecules was determined with a localization
precision of  
p.a.
=35±7 nm (Fig. S2).
Image analysis was done using programs written in MatLab (Math-
works Inc., USA) as described before (Schmidt et al., 1996). Briefly,
the signal acquired from individual eYFP molecules was fitted with a
2D-Gaussian and filtered with respect to peak intensity, peak width
and detection error thresholds. Subsequently, particle image-correlation
spectroscopy analysis, PICS, (Semrau and Schmidt, 2007) was used to
calculate the cumulative probability (cdf) of squared displacements. The
cdf revealed that CXCR4 diffusion was not homogeneous and was best
described with a model accounting for two or three fractions:
cdf2fr(r
2
, t) = 1 
 
↵ · exp(  r
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where ↵ is the fraction size of the receptors with corresponding char-
acteristic mean square displacement, MSD. The MSD was calculated for
different time lags up to 300 ms. Subsequently the MSD was analyzed
at different time lags to extract the diffusion coefficient (D):
MSD = 4 ·D · t
lag
(2.2)
where the offset s0 is a measure for the localization precision (s0 =
4 2). For each experimental condition the MSD and ↵ was calculated
separately. There was no difference in MSD values between resting and
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stimulated cells. Thus the data was re-analyzed jointly, with ↵ as a free
parameter. In indicated cases the radius of the confinement, r
conf
, was
calculated as in (Saxton, 1993):




Time-lapse microscopy was performed using a spinning disk (Yokogawa,
Japan) microscope (Zeiss, Germany) equipped with a motorized stage
(Maerzhauser, Germany) and a home-built autofocus system facilitating
time-lapse imaging at multiple positions. Imaging was done with a 10⇥
or 100⇥ objective (Zeiss, Germany) using brightfield, 488 nm or 514 nm
laser illumination at a specified time lag. Image analysis was done using
algorithms in MatLab (Mathworks Inc., USA).
2.2.10 Simulation of diffusion on a vesicle
We modeled free diffusion of the receptors with a diffusion coefficient
D
CXCR4(vesicle) = 0.2 µm2/s on the surface of a sphere with a diameter
d
vesicle









) representing a random distribution on the sphere
surface. At each time-lag ( t = 10 5s) each molecule was displaced to

































(2Dt). On this scale the surface of the sphere
was considered flat and the displacement of the molecule was taken as
a projection of p,
i
on the sphere surface by transformation into spherical
coordinates, while the r-coordinate was set as equal to the radius of the
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calculated the mean square displacement of the molecules in a projec-
tion to a plane to mimic the image of moving molecules in a microcope
image; MSD
sphere 2D. Our simulations revealed, that at t = 50 ms
MSD












2.3.1 CXCR4-eYFP is functional in A673-CXCR4 cells
We used the Ewing sarcoma-derived cell line A673 (Martinez-Ramirez
et al., 2003). For fluorescence imaging of CXCR4 we stably transfected
A673 wt cells with DNA encoding for CXCR4-eYFP (further referred
to as A673-CXCR4 cells). By visual inspection we estimated the trans-
fection efficiency to be ⇠50%. The expression level of CXCR4-eYFP
was estimated as described in (de Keijzer et al., 2008). Briefly, the cell’s
membrane surface was approximated as a spheroid with a short axis of 20
µm and long axis of 50 µm yielding a cell surface area of ⇠ 1.1⇥103µm2.
The fluorescence of CXCR4-eYFP at the apical membrane was detected
when illuminated at 2 kW/cm2 of 514 nm laser beam. The measured
signal (35⇥103 cnts/pxl) was divided by the signal predicted for indi-
vidual eYFP molecules under the same conditions, 220 cnts (Harms et
al., 2001; van Hemert et al., 2010). This calculation yielded an average
expression level of (4±1)⇥104 CXCR4-eYFP molecules per cell, which
is within the range of endogenous GPCR expression in mammalian cells
(Massotte, 2003). Confocal microscopy showed that CXCR4-eYFP was
primarily localized at the plasma membrane (Fig. 2.1A). CXCR4-eYFP
was uniformly distributed and did not form any macroscopic domains
(Fig. 2.1A, left).
To show that the CXCR4-eYFP was functional and that the fluo-
rescent tag (eYFP) did not alter CXCR4 signaling, we performed func-
tionality assays on the A673-CXCR4 cells. First, we measured intracel-
lular calcium release upon receptor stimulation using the Ca2+ reporter
Fluo4-AM. Cells were pre-incubated with Fluo4-AM, and subsequently
the change in fluorescence signal on global stimulation of the receptors
with 100 nM CXCL12 was monitored for individual cells. The increase
of the fluorescence intensity of Fluo4-AM corresponds to the increase of
cytoplasmic Ca2+. Figure 2.1B shows a representative measurement of
the change of fluorescence signal. The shown data were normalized to the
signal before cell stimulation. Similar to the results reported (Mueller et
al., 2013; Busillo et al., 2010; Venkatesan et al., 2003), stimulation with
















































Characterization of the A673-CXCR4 cell line. A. Confocal images of A673 cells
stably transfected with CXCR4-eYFP. The images were acquired by focusing on the
basal membrane (left) and in cytoplasmic cross-section of the cell (right). B. Ex-
amplary Ca2+ assay measurement. The curves represent the change in fluorescence
intensity of the Ca2+ indicator - Fluo4-AM - detected in non-transfected cells (black,
n=5) or cells transfected with CXCR4-eYFP (red, n=3), after uniform stimulation
with 100 nM CXCL12. The error bars represent the standard deviation. C. Appear-
ance of the endocytotic vesicles containing CXCR4-eYFP detected within 60 minutes
after cell stimulation with 100 nM CXCL12.
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CXCL12 caused a calcium release, within 20 seconds. Cells expressing
CXCR4-eYFP showed a 3.8±0.3 fold intensity increase after receptor
stimulation. This result indicates that CXCR4-eYFP were functional




Another pathway activated shortly after receptor stimulation induces
receptor endocytosis. Many GPCRs show internalization via clathrin-
dependent endocytosis. Some studies revealed, that upon stimulation
CXCR4 internalizes 2 minutes after activation (Venkatesan et al., 2003)
and reach a maximum internalization level after ⇠30 minutes (Venkate-
san et al., 2003; Rey et al., 2007). Therefore, we confirmed that CXCR4-
eYFP behaved similarly using 2 minutes time-lapse confocal imaging af-
ter CXCL12 addition (Fig. 2.1C). Endocytotic vesicles that contained
the fluorescent receptor were manually counted in each frame. Figure
2.1C shows, that after 20 minutes the number of vesicles increased sig-
nificantly and reached a maximum after 40 minutes. The lack of in-
ternalization at an earlier time could be explained (1) by the fact that
with confocal imaging only vesicles containing multiple copies of CXCR4-
eYFP could be detected; (2) only at a later time the newly formed vesi-
cle detached from the plasma membrane had travelled far enough (⇠600
nm) to be distinguishable as entities inside the cell (Serge et al., 2011;
Kirchhausen, 2010). This result confirmed that activation with CXCL12
leads to internalization of CXCR4-eYFP, and, hence, the receptor was
activating to the  -arrestin pathway.
In summary, we showed that CXCR4-eYFP was properly localized,
functional and did not alter the physiological response of the cells. There-
fore, we concluded that the A673-CXCR4 cell line was suitable for the
study of CXCR4 dynamics and to derive physiological effects.
2.3.2 CXCR4 do not homodimerize upon activation in
A673 cells
The biochemical responses of CXCR4 upon stimulation are well estab-
lished (Teicher and Fricker, 2010). CXCL12 binding to CXCR4 facil-
itates conformational changes of the receptor leading to the activation
of multiple pathways (Teicher and Fricker, 2010). However, knowledge
about a possible role of CXCR4 dimerization upon activation is still lim-
ited. Earlier reports showed that in 293T cells CXCR4 can be observed
in a homodimeric configuration in resting cells and undergos further ho-















Normalized probability density of the intensity of eYFP molecules collected during
measurements with or without stimulation. Different colors represent different con-
centrations of CXCL12.
modimerization upon stimulation with CXCL12 (Springael et al., 2005;
Hamatake et al., 2009; Vila-Coro et al., 1999). To test for the presence
of homodimers/multimers of CXCR4-eYFP in A673, we analyzed the
signal intensity of >105 YFP signals that were detected on the plasma
membrane of transfected cells with and without stimulation by CXCL12
(Fig. 2.2). For individual eYFP molecules at an illumination intensity
of 2 kW/cm2 at 514 nm and an illumination time of 5 ms we expected
a signal of ⇠220 cnts for individual YPF-molecules (Harms et al., 2001;
van Hemert et al., 2010). The appearance of larger signals (>400 cnts)
would indicate, that two or more eYFP molecules were detected within
the same diffraction limited signal, therefore pointing to receptor dimers
or multimers, respectively (Schmidt et al., 1996; Meckel et al., 2011).
For resting cells (0 nM) the signal distribution showed only one peak
with the maximum at ⇠200 cnts (Fig. 2.2, black), corresponding to
CXCR4-eYFP monomers. The monomeric distribution did not change
upon stimulation with various concentrations of CXCL12 up to 200 nM
(Fig 2.2), indicating that CXCR4 stayed monomeric even after activa-
tion.
In summary, CXCR4 is a monomeric protein on the plasma mem-
brane of A673 cells independent of its activation state by CXCL12.
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2.3.3 Activation of CXCR4 causes immobilization of the
receptors
To get deeper insights into the behavior of CXCR4 on the plasma mem-
brane and how it is regulated upon stimulation we applied single-molecule
fluorescence microscopy and studied the diffusion dynamics of individual
CXCR4-eYFP receptors on the millisecond time-scale at a position ac-
curacy of  
p.a.
=35±7 nm (Fig. S2). A 514 nm laser beam at 2 kW/cm2
was used in the triggered mode (5 ms illumination) to acquire movies
with 1500 frames at a frame-rate of 20 Hz. Each detected fluorescent
signal was fit to a 2D-Gaussian (Fig. 2.3A) and filtered with respect
to the previously determined eYFP footprint (van Hemert et al., 2010).
Subsequently, analysis by particle image correlation spectroscopy, PICS,
(Semrau and Schmidt, 2007) was applied to construct the cumulative
probability density functions (cdf) of square displacement for various
time lags. Our results revealed that in resting cells the cdf were best
described with a model accounting for two fractions, a mobile receptor
fraction and an immobile receptor fraction (Fig. S3A, green line). The
fraction size (↵) and mean square displacements (MSD1 and MSD2) were
calculated according to eq.(2.1) for various time lags from 50 ms up to
300 ms. The change of MSD1 and MSD2 varied with the time lag as
shown in Figure 2.3B. MSD2 did not change over time and was equal
to 0.013±0.001 µm2. It is important to note that the value of MSD2
was significantly larger than that predicted for an immobile receptor of
4 2
p.a.
= 0.005±0.001 µm2. This indicates that processes at a shorter time
scale (<50 ms), which we could not detect with our imaging settings were
responsible for this initial increase. Nonetheless, for brevity, we further
refer to the receptor fraction with MSD2 as immobile.
MSD1 showed a linear dependence on the time lag as predicted for
free diffusion (Fig. 2.3B). Fitting according to eq.(2.3) yielded D
CXCR4=
0.18±0.01 µm2/s. This value is in good agreement with the diffusion
coefficient determined, e.g. for the cAMP-receptor in Dictyostelium
(0.17±0.02 µm2/s) (de Keijzer et al., 2008) or other GPCRs in mam-
malian cells (Calebiro et al., 2013; Lill et al., 2005). The fraction of
mobile receptors comprised ↵=81±3% of the receptors (Fig. 2.3, black)
To study how the activation of CXCR4 influences the behavior of the
receptor on the plasma membrane, we applied global stimulation of the
cells with CXCL12. CXCL12 was added to the cells right before imaging
and single-molecule data were collected within the following hour. Up to
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Single-molecule characterization of CXCR4 diffusion in resting cells and upon global
stimulation with CXCL12. A. Single-molecule imaging scheme. Scale-bar: 2 µm. B.
Mean square displacement (MSD) vs time plot. MSD of mobile (blue) and immobile
(purple) receptors as resulting from a simultaneous fit of the resting and CXCL12
stimulated cells’ data sets. C. Dependence of the mobile receptor fraction on the
CXCL12 concentration. The color-code correspond to the one used in Figure 2.2. D.
The mobile receptor fraction detected at different time points after addition of 100 nM
CXCL12 within one experiment. Cell1-cell5 represents five individual cells imaged
subsequently within one experiment (0-60 min). ‘All’ represent the mobile receptor
fraction detected by simultaneous analysis of all cells imaged within one experiment.
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five cells were imaged sequentially during one experiment. Each cell was
taken as a representative of a 10-15 minutes time window after CXCL12
addition. At least 20 cells were imaged per condition. As shown in Figure
2.3D the mobile receptor fraction size (↵) detected for every individual
cell during activation exhibited a similar value as for the following cells.
The mobile receptor fraction determined from simultaneous analysis of
all cells within the experiment (Fig. 2.3D, All) exhibited the same value
as that of an individual cells. This result suggests that receptor stim-
ulation had a long-lasting effect on the receptor mobility and did not
change over time within 60 min.
Our results showed a strong correlation between receptor stimulation
and receptor mobility in a concentration-dependent manner. Addition
of increasing concentrations of CXCL12 systematically shifted the cu-
mulative probability distribution of square displacements to lower values
(Fig. S1B). The shift in the cdf was attributed to a redistribution of the
receptor fractions. As shown in Figure 2.3C, the mobile receptor fraction
decreased from ⇠80% (no CXCL12) to ⇠45% (200 nM CXCL12) in a
CXCL12 concentrations-dependent manner. This finding was in agree-
ment with earlier findings for other GPCRs (Lill et al., 2005; Jacquier
et al., 2006). It is noteworthy that an increase in receptor mobility has
been found for cAMP-receptor in Dictyostelium (de Keijzer et al., 2008)
and for GABAB in HEK293 cells (Calebiro et al., 2013).
In summary, our results showed that CXCR4 on the plasma mem-
brane is either freely diffusing or immobile. CXCR4 is immobilized upon
stimulation with CXCL12 in a concentration-dependent manner.
2.3.4 Actin cytoskeleton is not responsible for CXCR4
immobilization
Many studies agree that GPCR dynamics is actin-cytoskeleton regulated
(Andrews et al., 2008; Luo et al., 2006; Tsao et al., 2001; Papadopoulou
et al., 2009). Thus, we decided to test whether the actin cytoskeleton
underlining the plasma membrane could be involved in modulation of
CXCR4 mobility. For this purpose, we induced actin depolymerization
by Latrunculin B (LatB). Pre-incubation with LatB for 30 minutes was
sufficient to effectively deplete actin (Fig. S1). LatB induces only tem-
poral actin-cytoskeleton depolymerization. Thus, we analyzed the data
acquired within the first 30 minutes after medium exchange, while the
data collected at 30-60 minutes after which the membrane-skeleton was
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Effect of different drug treatments. A. The fraction of mobile CXCR4-eYFP in
cells pre-treated with LatB (grey) without or with (green punctate pattern) global
stimulation by 100 nM CXCL12, compared to the mobile receptor fraction measured
in control cells without (black) and with (green) stimulation. LatB provided temporal
actin depletion, therefore the acquired data was split accordingly: 0-30 min and 30-
60 min. B. Fraction of mobile CXCR4-eYFP measured in PTX pre-treated (purple)
cells without and with (green punctate pattern) activation, compared to control cells
without (black) and with (green) uniform stimulation with 100 nM CXCL12. C. The
MSD vs time plot of the immobile (purple), confined (green) and freely mobile (blue)
receptors measured in CHZ pre-treated cells. Solid lines represent the respective
fit of the data. The size of the confinement zone was estimated from the linear fit
to the plateau and yielded r
conf
= 236±6 nm. D. The mobile receptor fraction in
CHZ treated cells presented by two sub-fractions of mobile receptors: freely diffusing
(light blue) and confined (dark green). Uniform admission of 100 nM CXCL12 (green
punctate pattern) caused a drastic change in the ratio of mobile subpopulations. The
total size of the mobile fraction in CHZ pre-treated cells was comparable to the one
in the control cells without (black) or with (green) CXCL12 admission.
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re-established served as a control.
To our surprise actin depolymerization did not lead to an increase
of the mobile receptor fraction but rather to a decrease to ⇠61% (Fig.
2.4A, 0-30 min) in non-stimulated cells. Receptor activation with 100 nM
CXCL12 slightly changed the mobile receptor fraction to 69% (Fig. 2.4A,
0-30 min). Data collected after actin repolymerization (30 min after
medium exchange) replicated the results acquired for cells with intact
actin cytoskeleton (Fig. 2.4A, 30-60 min). In resting cells, the fraction
of the mobile receptors reached 77±2% and in the cells stimulated with
CXCL12, it dropped to 56±2%.
In summary, our results suggest that in resting cells with intact actin
skeleton, the immobile CXCR4 receptors were not anchored to the actin
cytoskeleton. Activation by CXCL12 induced an actin-dependent pro-
cess promoting CXCR4 immobilization. Thus, our result suggests that
actin might have an indirect effect on CXCR4 regulation which will be
discussed later.
2.3.5 CXCR4 in endocytotic vesicles contribute to the
immobile receptor fraction
Upon stimulation many GPCRs proceed to internalization (Tsao et al.,
2001; Schwartz et al., 2012; Teicher and Fricker, 2010). Activated GPCRs
are known to bind to  -arrestin, which in turn links them to the AP2
adapter complex (Vassilieva and Nusrat, 2008) and facilitates their clath-
rin-dependent endocytosis. Given that CXCR4 is known to internalize
via clathrin-dependent endocytosis upon stimulation and, at the same
time, to undergo constitutive internalization without stimulation (Bhan-
dari et al., 2007), we further hypothesized that receptor internalization
could possibly explain the drop of the mobile CXCR4 receptor frac-
tion upon stimulation. For the experiments we used chlorpromazine
(CHZ), an inhibitor of clathrin-dependent endocytosis. CHZ causes loss
of clathrin from the cell surface in the coated pits and, therefore, pre-
vents formation of new clathrin-coated vesicles (CCVs) (Wang et al.,
1993; Stuart et al., 2006). Effect of CHZ is very cell-type dependent
(Vercauteren et al., 2010). For A673-CXCR4 cells 30 min incubation
with 25 µM CHZ was sufficient to inhibit clathrin-dependent endocyto-
sis of CXCR4 effectively, while not causing dramatic cytotoxicity (data
not shown).
Single-molecule imaging revealed that CHZ pre-treated cells exhib-
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ited the same mobile CXCR4 receptor fraction (↵ = 74±9%) as control
cells (↵ = 81±3%). However, in the CHZ pre-treated cells the mobile
receptor fraction was composed of two sub-fractions, a freely diffusing
fraction (62±7%) and a receptor fraction that exhibited confined diffu-
sion (12±9%) as reflected by a sub-linear increase of MSD with timelag
(Fig. 2.4C,D). Both sub-fractions of mobile receptors showed similar
diffusion coefficients as the fraction of mobile receptors in resting cells,
DCXCR4 (CHZ) = 0.16±0.02 µm2/s. The size of the confinement zone
was estimated from a fit to the plateau in the MSD vs time plot (Fig.
2.4C) according to eq.(2.3) in Materials and Methods and yielded r
conf
= 236±6 nm.
Given the typical radius of a clathrin-coated vesicle of ⇠75-100 nm
(McMahon and Boucrot, 2011), which contains a surface area of 0.07-0.13
µm2 equal to the area covered by the confinement zone in our experi-
ments, we suggest that receptors exhibiting confined diffusion correspond
to the receptors trapped in a pre-cursor structure of clathrin-coated pits.
Thus, in CHZ pre-treated cells mobile receptors undergoing constitutive
internalization accumulate in a precursor structure of clathrin-coated
pits and stay locked there since endocytosis cannot proceed.
When CHZ pre-treated cells were stimulated with 100 nM CXCL12,
the fraction of mobile receptors decreased (↵ = 56± 6%) and the distribu-
tion of receptors between freely diffusing and confined fractions changed
dramatically (Fig. 2.4D). Nearly all receptors showed confined diffusion,
while only a small fraction showed free diffusion (52±5% and 4±3%,
respectively), suggesting that activated receptors proceed to internal-
ization. This is in good agreement with our internalization experiment
(Fig. 2.1C) and with data from other groups (Venkatesan et al., 2003;
Rey et al., 2007), showing that upon stimulation the rate of CXCR4
internalization increases.
In summary, CHZ prevents the formation of clathrin-coated vesicles
and, hence, receptors proceeding to internalization get trapped in con-
fined areas reminiscent of precursor structures of coated pits. Thus, our
results suggest, that the immobile fraction of receptors upon stimulation
was caused by CXCR4 trapped in clathrin-coated vesicles, in which the
diffusion could not be resolved (see below).
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2.3.6 G-proteins control CXCR4 immobilization
Up to date, internalization of GPCR’s is considered as a way of receptor
desensitization. Our results, suggest that internalizing receptors appear
as immobile. However, the ratio of mobile and immobile fractions in
stimulated CHZ pre-treated cells resembled such of the control cells. At
the same time we find that immobilization of CXCR4 correlated with
activation of receptors. Therefore, having established a correlation be-
tween receptor mobility and signaling, we were interested in how receptor
mobility is affected when the signaling chain is disrupted at the level of G-
proteins. Previous reports showed a change in G-protein mobility while
the cAR1 receptor was stimulated (van Hemert et al., 2010). Stimulation







(Teicher and Fricker, 2010). Kleemann et al. showed ele-
vated coupling of G
↵i
to CXCR4 upon receptor stimulation (Kleemann
et al., 2008). This coupling of the G
↵i
on the cytosolic side should not
per se influence the receptor dynamics. However, hypothesizing that the
G
↵i
pathway activation might result in formation of a supramolecular
scaffold (Ritter et al., 2009) for further signalling, we probed how the
interaction of CXCR4 with the G
↵i
subunit could modulate the mobile
receptor fraction.
In our experiments we used pertussis toxin (PTX) as an agent re-
sulting in loss of coupling of G
↵i
and the receptor (Moss et al., 1984;
Mangmool and Kurose, 2011). We pre-incubated A673-CXCR4 cells
with PTX for 5 hours. During the experiments PXT was also present
in the medium. As predicted, in resting cells, single-molecule imaging
of CXCR4-eYFP did not show any change in the diffusion coefficient of
the receptors. Moreover, the mobile receptor fraction did not change
compared to the control without PXT (Fig. 2.4B), suggesting that if
G
↵i
was coupled to CXCR4 it had no measurable impact on the recep-
tor dynamics. However, when 100 nM CXCL12 was added to the cells,
no significant drop in the mobile receptor fraction was observed (Fig.
2.4B). This behavior was in contrast to the decrease in the mobile recep-
tor fraction detected for CXCR4 receptors upon stimulation in control
cells (Fig. 2.4B, green bar). This result supports our earlier conclu-
sion that a bigger fraction of immobile receptors is strongly correlated
to receptor signalling.
In summary, our results imply that the decrease in the mobile recep-
tor fraction upon stimulation must be interpreted as an outcome of the
































Ca2+ assay. The curves represent the change in fluorescence intensity of the Ca2+
indicator - Fluo4-AM - detected in cells pre-treated with CHZ (light blue) or in control
(black) cells after uniform stimulation with 100 nM CXCL12.
of the subsequent G
↵i
-pathway activation potentially resulting in for-
mation of a supramolecular scaffold (signalosome, see Fig. 2.6), while
blocking the receptor interaction with G
↵i
lead to receptor mobility that
did not change upon stimulation.
2.3.7 Cross-talk between G-protein dependent and inde-
pendent pathways
Our results showed, that immobilization of CXCR4 upon stimulation is
facilitated via receptor endocytosis. At the same time the G
↵i
-dependent
pathway also lead to CXCR4 immobilization. Taken together, these re-
sults suggest that G-protein dependent and independent pathways are
cross-regulated. Thus, we checked whether a G-protein dependent path-
way would be affected by inhibition of CXCR4 endocytosis. We per-
formed a Ca2+ assay in the cells under different conditions. Cells with
inhibited clathrin-dependent endocytosis (pre-treated with CHZ) showed
no Ca2+ release upon CXCR4 activation (Fig 2.5). This result implies,
that the G-protein independent pathway of receptor internalization was
































































































































































































Current model. Binding with CXCL12 CXCR4 is activating G-protein dependent
(left) and independent (right) pathways. Activation of the biochemical pathways
result in CXCR4 immobilization either in super-molecular signalosome, causing en-
hanced signalling, or in the clathrin-coated vesicles, resulting in receptor internaliza-
tion, imply a cross-talk between these signalling cascades.
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In summary, we suggest that two processes together regulate CXCR4
mobility and thus activation/signalling. Endocytosis driven immobiliza-
tion leads to desensitization while G-protein driven local signalosome
formation might result in signal enhancement (Fig. 2.6). Together, both
processes regulate the overall cellular response.
2.4 Discussion
GPCR signalling is a complex process in which only parts have been un-
raveled. Activation of CXCR4 promotes signalling through G-proteins
resulting in expression of certain genes, cells survival/proliferation, chemo-
taxis, etc. Simultaneously G-protein independent pathways, e.g.  -
arrestin, are activated and result in receptor desensitization (Teicher
and Fricker, 2010). All the biochemical pathways are studied in detail,
but the role of the receptor dynamics on the plasma membrane remains
poorly understood.
To elucidate the molecular mechanism of CXCR4 signal transduc-
tion, we studied CXCR4 during activation using the receptor mobility
as a marker. Our results revealed that already in the resting cells receptor
diffusion was not homogeneous. We detected two receptor species, one
mobile and one immobile. Activation of CXCR4 with CXCL12 caused
a concentration-dependent decrease of the mobile receptor fraction, in-
dicating a correlation between receptor signalling and diffusion on the
plasma membrane. Our data gives information on receptor diffusion
at millisecond time scales, while, most biochemical or other receptor-
signalling processes require longer time, e.g. endocytosis of a receptor
takes ⇠1 minute (Cocucci et al., 2012; Boulant et al., 2011). In this re-
spect, our results depict a snapshot. However, we did not observe a time
dependent change in the mobile receptor fraction (Fig. 2.3D), meaning
that there was a constitute fraction of immobile receptors.
Many studies of GPCRs agree that receptors dynamics/signalling
strongly depends on the actin cytoskeleton. Actin remodelling was re-
ported to have a key role in the pro-apoptotic responses upon mAR
activation (Papadopoulou et al., 2009). Luo et al. showed that a big
portion of CXCR4 is pre-coupled with the cortical actin binding protein
- cortactin (Luo et al., 2006). Stimulation with CXCL12 induced further
translocation of cortactin from endosomal compartments and colocaliza-
tion with CXCR4. However, our results did not show actin-dependent
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changes in the diffusion coefficient of CXCR4, and actin depletion did
not cause the predicted increase in receptor mobility. In contrast, in
the actin depleted cells the fraction of mobile receptors was decreased
compared to control. These results imply that there is no direct phys-
ical interaction between receptors and actin. However, the change in
the CXCR4 mobile fraction indicated, that there was actin-dependent
regulation of receptor mobility.
Actin is known to play an important role in sorting of GPCRs to di-
verse membrane pathways after endocytosis (Tsao et al., 2001; Samaj et
al., 2004). For instance, linking of the  2-adrenoreceptor to actin inhibits
trafficking of endocytosed receptors to lysosomes and promotes their re-
cycling to the plasma membrane (Tsao et al., 2001). Therefore, during
actin cytoskeleton depletion one could expect that most of the receptors,
which are endocytosed, follow the lysosomal route instead of being recy-
cled to the plasma membrane (Fig. 2.6, right side). Such a process could
lead to a change in the balance of different fractions of receptors present
on the plasma membrane. Moreover, there are indications that actin is
involved in all forms of endocytosis (Samaj et al., 2004). Though, actin
was reported to function as a late component of clathrin-dependent en-
docytosis (McMahon and Boucrot, 2011) it is responsible for a range of
processes (Kichhausen, 2009). EM imaging and life-cell imaging showed
that depletion of the actin cytoskeleton caused an increased fraction of
shallow and curved clathrin-coated structures on the plasma membrane
in comparison to invaginated structures and formed vesicles (Yarar et al.,
2005; Boulant et al., 2011). Furthermore, it was shown that actin poly-
merization at the plasma membrane controls both the alignment and mo-
bility of clathrin-coated vesicles, facilitates the internalization step, and
drives rapid transport of early endosomes away from the plasma mem-
brane in the cytosol (Samaj et al., 2004). Hence, actin depletion can be
considered as one form of indirect clathrin-dependent endocytosis inhibi-
tion at a later stage. Accordingly, in actin-depleted resting cells, CXCR4
undergoing constitutive internalization stall in vesicles, which cannot be
removed from the plasma membrane (Fig.2.6, right side). These recep-
tors contribute to the observed immobile fraction (see below). During
receptor activation, disturbed vesicle formation and/or vesicle scission
could result in CXCR4 failing to proceed with endocytosis and to show
the accompanying decrease in the mobile receptor fraction.
In our experiments we used CHZ to directly address the question of
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how endocytosis interferes with the mobility of CXCR4 on plasma mem-
brane. CHZ causes loss of clathrin from the cell surface in the coated
pits and, therefore, prevents formation of new clathrin-coated vesicles
(CCVs) (Wang et al., 1993; Stuart et al., 2006). However, loss of clathrin
from the cell surface would not affect the early stages of clathrin-coated
structure (CCS) formation. Clathrin-coated vesicle formation consists
of five steps: (1) nucleation, (2) cargo selection, (3) coat assembly, (4)
scission and (5) uncoating (McMahon and Boucrot, 2011). The first two
steps are promoted by a number of initiation proteins, e.g. FCHO 1,2,
Epsin and adaptor proteins, e.g.  -arrestin. These proteins result in
initiation of the membrane curvature and receptor recruitment (Fig.2.6
middle). Further, the AP2 adaptor protein and clathrin are recruited
during clathrin-coated pit maturation and coat assembly. Thus, a mem-
brane invagination appears and progresses before recruitment of clathrin
(McMahon and Boucrot, 2011). Therefore, CHZ pre-treated cells could
still form precursor structures of clathrin-coated pits (pCCS), while fur-
ther internalization was blocked. This mechanisms of the endocytosis
inhibition is favorable when addressing the endocytosis-mediated regu-
lation of the receptor dynamics on the plasma membrane. Our data
showed, that inhibition of a clathrin-dependent endocytosis with CHZ
caused appearance of a receptor fraction undergoing confined diffusion.
During CXCR4 activation in CHZ pre-treated cells all mobile receptors
were diffusing in a confinement zone. The radius of the confinement zone
(236±6 nm) suggested that the confinement corresponded to precursor
CCS (pCCS). Upon stimulation CXCR4 was driven to CCVs, but due
to the CHZ pre-treatment, the receptors were confined to pCCS.
Thus, in untreated cells CXCR4 would be trapped in CCVs after
stimulation. As the typical size of a CCV equals 100-200 nm which is
within the axial resolution of our microscope (⇠1 µm) (Fig.2.6), diffusion
of the receptors on the vesicle surface will be detected as a 2D projection
. To elucidate the effect hereof, we modeled free diffusion of the receptor
on a vesicle with a diffusion coefficient D
CXCR4(vesicle)=0.2 µm2/s on the
surface of a vesicle with a diameter d
vesicle
= 150 nm and subsequently
analyzed the 2D-projection of the data. Our simulations revealed, that
the MSD
sphere 2D linearly increased with timelag and reached a plateau
at a time lag of t = 50 ms (Fig. S4), which corresponds to the time lag
of our single-molecule measurements. The simulations further revealed
that the plateau value is given by MSD(sphere 2D)(t = 1) = 43R
2,
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where R is the vesicle radius. Further, taking into account the positional
accuracy of  
p.a.
= 35±7 nm, and the value we found for MSD2,  MSD2





4 2(p.a.). Using our experimental findings we calculated a value RMSD2 =
78±3 nm which was very similar to the size of a clathrin-coated vesicle.
Together these findings showed that the immobile receptors we found can
be attributed to receptors diffusing in a CCV. Thus, CXCR4 undergoing
constitutive internalization (Bhandari et al., 2007) would contribute to
the immobile receptor fraction in resting cells and the increase of the
immobile fraction during activation would be related to an elevated level
of clathrin-dependent endocytosis of CXCR4. Hence, clathrin-dependent
endocytosis is involved in regulation of CXCR4 mobility on the plasma
membrane.
Stimulation experiments showed a concentration-dependent decrease
of the mobile receptor fraction, indicating that receptor immobilization
was correlated with CXCR4 activation. This was further confirmed by
experiments in cells treated with PTX. Detachment of G
↵i
from CXCR4
altered the ratio of mobile to immobile receptors in response to CXCL12
stimulation, compared to non-treated cells. There was no decrease in the
mobile receptor fraction, supporting our hypothesis of correlated CXCR4
mobility on the plasma membrane and signalling. As clathrin-dependent
endocytosis is G-protein independent and the majority of biochemical
signalling of CXCR4 is mediated through activation of the G
↵i
-subunit,
PTX is a tool to separate G-protein dependent and independent path-
ways. In contrast to neuroblastoma cells, where G
↵i
detachment with
PTX failed to inhibit internalization of CXCR4 upon CXCL12 addition
(Clift et al., 2014), our experiments suggest that in Ewing sarcoma cells,
disrupted receptor signalling prevented receptor internalization. This
idea is supported by the number of reports claiming an important role
of caveolin (main component of caveolin-dependent endocytosis; Pelk-
mans and Helenius, 2002) in signalling of various molecules in Ewing
sarcoma (Martins et al., 2011; Sainz-Jaspeado et al., 2010; Tirado et
al., 2006; Sainz-Jaspeado et al., 2013). For instance, it was shown that
in Ewing sarcoma cells blockade of IGF1R endocytosis inhibits the re-
ceptor’s signalling (Martins et al., 2011). Furthermore, in our experi-
ments, CHZ pre-treatment disturbed G
↵q
-dependent Ca2+ release upon
CXCL12 stimulation.
In conclusion, here we showed that in Ewing sarcoma derived A673
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cells the CXCR4 receptor mobility on the plasma membrane is strongly
correlated with receptor signalling. Activated receptors are immobilized
in a concentration-dependent manner. Immobilization of the receptor is
facilitated via clathrin-dependent endocytosis structures, e.g. vesicles,
or via G
↵i
- initiated supramolecular scaffolding. Inasmuch as these pro-
cesses lead to opposite results (desensitization or signal enhancement in
signalosomes, respectively) balanced regulation of G-protein dependent
and independent pathways is required for proper receptor signal trans-
duction.
2.5 Supplemental figures 55
2.5 Supplemental figures
Before LatB treatment 
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Figure S1
LatB treatment. Cells pre-treated with 500 nM LatB for 30 min loose their shape and
show round morphology. After media change actin stays depleted for up to 30 min,
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Figure S2
Positional accuracy of single molecules in x (A) and y (B). The data was collected
for over 105 molecules and thresholded with respect to the signal width and intensity.
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A. Cumulative distribution of square displacements in resting (control) cells. Data
points (blue dots) were best fit with a two fraction model (green curve), while a one
fraction model (pink curve) failed. B. Cumulative distribution of square displace-
ments of CXCR4-eYFP constructed for the cells with uniform admission of different
concentrations of CXCL12 - from ⇠6 nM (red) to 100 nM (green) - are shifted com-


















Simulation of the free diffusion on the vesicle compared to MSD2 data and positional
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Chapter 3
Differential activation modes
of G↵-subunits in chemokine
receptor signaling1
1Elena Beletkaia and Thomas Schmidt
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G-proteins are the front-line signal transducing partners of the G-
protein coupled receptors (GPCRs). A single GPCR can be activating
various G-proteins. It is believed that a specific combination of vari-
ous G-proteins together with a tight temporal control of their activation
is required to ensure faithful and specific signalling through downstream
biochemical cascades. Presumably this level of control is facilitated by
different modes of coupling of the G-protein to the receptor. Here we
investigated the interaction of the chemokine receptor CXCR4 with its





different coupling modes. Variation in the receptor/G-protein interaction
was aligned with the subsequent pathways activation and potentially play
an important role in regulating CXCR4 specific signalling in cells.
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3.1 Introduction
G protein-coupled receptors (GPCRs) are a unique family of membrane
receptors that control a wide variety of physiological functions from em-
bryogenesis to immune response. Counting to ⇠800 members (Fredriks-
son et al., 2003), GPCRs do not only share a common seven transmembra-
ne-helix structure, but they also share their front-line signal transduction
partners, the G-proteins. The heterotrimeric guanine nucleotide-binding
proteins (G-proteins) are encoded by 35 genes in the human genome
(Milligan and Kostenis, 2006). The 45 kDa heterotrimers includes the
35 kDa ↵-subunit and two 8-10 kDa polypeptides defined as the  - and
 -subunits (Milligan and Kostenis, 2006). There are 16 different ↵-, 5






, respectively). The G
↵
sub-
units are sub-divided into 4 groups: G
↵
s which regulates an increase
in intracellular cyclic adenosine mono-phosphate (cAMP) concentration,
G
↵i/o
which regulates a decrease in cAMP concentration, G
↵q/11 which
activates phospholipase C (PLC) subsequently leading to increased cyto-
plasmic Ca2+ levels, and G
↵12/13 which regulates signalling by the small




subunits occur presumably as stable het-
erodimers (G
  
) and are shown to activate multiple pathways, which are
partially overlapping with those of the G
↵
subunits. The precise signal
translation from multiple ligands to the specific GPCR is enabled by a
peculiar combination of the G-protein subunits activating corresponding
specific downstream biochemical response.
The mechanisms by which specificity in receptor/G-protein interac-
tion is controlled are not yet well understood. Knowledge about these
mechanisms is highly required for the development of novel drugs leading
to more precise targeting, and thus avoiding undesired pharmacological
side effects. Extensive research of the past years resulted in the develop-
ment of two models for this initial receptor/G-proteins interaction (Hein
and Bunemann, 2008; Hein et al., 2005). The first, so called ‘collision
coupling’ model, assumes that G-proteins and receptors exist as inde-
pendent entities in the plasma membrane which, by diffusion, are able
to collide initiating the interaction and subsequent activation of the G-
protein. The second, so called ‘pre-coupling’ model, assumes that the
receptor/G-protein form a stable complex prior to activation, which on
activation is disrupted and the G-protein activated. Activation of the G-





and a split of the trimer into a G
↵
monomer and a G
  
heterodimer.
68 G-protein activation mode by CXCR4
The mode of GPCR and G-protein interaction has been addressed
for various systems using fluorescence-based methods. Experiments us-
ing fluorescence recovery after photobleaching (FRAP) showed that the
↵2A-adrenergic receptor did not form stable complexes with its respec-
tive G
↵i
(Qin et al., 2008), while for the µ-opioid receptor such interac-
tion with G
↵o
has been found for resting cells (Qin et al., 2008). Further
bioluminescence resonant energy transfer (BRET) and fluorescence res-
onant energy transfer (FRET) approaches showed that interaction of
GPCR and G-proteins is a fast, transient process on a time scale of 30-
50 ms, suggesting their plausible pre-coupled state (Lohse et al., 2008).
Upon activation the FRET signal decreased rapidly, which would be pre-
dicted for the dissociation of a pre-complex (Lohse et al., 2008). However,
FRET also revealed that only a small fraction of G
↵i
was pre-coupled
to the ↵2-adrenoceptor (Hein et al., 2005). Single-molecule fluorescence
imaging showed that the G-proteins were pre-coupled to the chemokine
cAMP-receptor 1 (cAR1) in Dictyostelium discoideum (van Hemert et
al., 2010). Hence, different studies provide support for both models, sug-
gesting that the coupling mode of GPCRs and G proteins might be not
universal. It seems tempting to speculate that the differential mode of
operation for GPCR/G-protein coupling could be an additional mecha-
nism for spatial and temporal signal propagation control in cells.
An interesting GPCR to study with respect to its coupling mode
is the chemokine receptor CXCR4. CXCR4 activates four different G
↵





Fricker, 2010). We have shown in a prior study that the mobility of
CXCR4 in the plasma membrane reflected its interaction with the re-
spective G-protein. The interaction with G
↵i
was essential for receptor
immobilization, while the G
↵q
signalling was interfering with CXCR4
internalization after stimulation by its specific ligand CXCL12 (Chapter
2 of this thesis). In the current study, we further addressed the question
of the mechanism of CXCR4/G-protein interaction and its involvement
in receptor signalling in the Ewing sarcoma-derived cell line A673. Our





coupling models. While the G
↵i
-subunit obeyed the ,collision coupling,
model, the G
↵q
-subunit appeared as pre-coupled with the receptor. Our
findings suggest that G-protein activation by CXCR4 occurs in a se-
quential manner: an early response by the pre-coupled G
↵q
, followed
by a later response by G
↵i
. Whether and how this time-dependent dif-
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ferentiation in G-proteins activation might lead to further specificity in
CXCR4 signalling will have to be explored in the future.
3.2 Materials and Methods
3.2.1 Cell culture and transfection
Ewing sarcoma A673 wt cells and A673 cells stably transfected with
the chemokine receptor CXCR4 (A673-CXCR4) were cultured in IMDM
cell culture medium (Gibco, USA) supplemented with 10% fetal bovine
serum (200 µg/mL; FBS, Gibco, USA) at 37 C and 5% CO2. For tran-








0.5⇥105 A673 cells were plated on 0.35 mm diameter culture dishes
(Ibidi, Germany) and allowed to adhere overnight. For the transfec-
tion mix 1 µg of respective plasmid DNA was diluted in 93 µL serum-
free medium and mixed with 4 µL Turbofect. The mix was vortexed
and incubated for 20 minutes. Cells were incubated with 100 µL of the
transfection mix for 2 hours, followed by medium change and overnight
incubation to allow for protein synthesis. For co-transfection an equal
amount of respective DNA was pre-mixed to a final concentration of
1 µg/µL and total weight of 1 µg plasmid DNA and was used in the
transfection mixture.
3.2.2 Confocal microscopy
Confocal microscopy was performed using an Axiovert200 microscope
(Zeiss, Germany) combined with a spinning disk unit (CSU-X1, Yoko-
gawa, Japan) and an emCCD camera (iXon 897, Andor, UK) (van Hoorn
et al., 2014). Imaging was performed using a 100⇥/NA1.4 objective
(Zeiss) at 514 nm (Cobolt) laser illumination. Time-lapse imaging was
performed at 1 second time lag. Where indicated, CXCL12 was added
to the media to a final concentration of 100 nM present in the media
during the time of the entire experiment.
3.2.3 Single-molecule imaging
Single-molecule fluorescent imaging was carried out using a combination
of wide-field microscopy with highly-sensitivity CCD (Princeton Instru-
ments, USA) or high-sensitivity CMOS (Orca flash 4.0v2, Hamamatsu,
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Japan) camera detection as described in detailed elsewhere (Schmidt et
al., 1996). To excite individual YFP molecules illumination with a 514
nm laser set to 2 kW/cm2 intensity and illumination time of 5 ms was
applied. The signal was subsequently detected on the camera for 1000-
1500 frames at a frame-rate of 20-40 Hz. Each fluorescence signal was
fit to a 2D-Gaussian intensity distribution yielding the G-protein posi-
tion to   = 40 nm accuracy. Subsequently all results were filtered with
respect to a previously determined YFP-footprint signal (van Hemert et
al., 2010). For those data particle image correlation spectroscopy (PICS)
was used to construct the cumulative distribution of square displacement
(cdf) characterizing the protein’s mobility (Semrau and Schmidt, 2007).
Data were subsequently fit to an n = 2 or n = 3 fraction model:











where r2 is the squared displacement, ↵
i
are the respective normal-
ized fraction sizes (⌃↵
i
= 1) of proteins with characteristic mean square
displacement MSD
i
(t) and lag-time t. For free diffusion the MSD is





· t+ s0 (3.2)













In eq.(3.2) and eq.(3.3) s0 is an offset in MSD due to the localization
precision of individual proteins (s0 = 4 2). Generally the MSD and ↵
were calculated separately for each experiment. In some indicated ex-
periments data were fit globally, with ↵ as a free parameter and common
MSDs.
3.3 Results
3.3.1 Receptor interaction is required for G-protein lo-
calization to the plasma membrane
Here we used an Ewing sarcoma-derived cells line, A673, to follow the G-
protein activation upon cell-stimulation through the chemokine receptor
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-YFP including co-transfection with YFP-G
 2 and G 1
(further referred to as G
  
-YFP) as described in Materials and Methods.
It should be noted that transfection was additional to the endogenous
G-protein levels present in A673 cells. Confocal imaging revealed that
the expressed YFP-labeled G-proteins did not show prominent plasma
membrane localization (Fig. 3.1A). The YFP-signal was predominantly






do have a mem-
brane anchor, this suggests that the lipid anchor was not sufficient for
plasma membrane localization and that specific interactions of the G-
proteins with their respective GPCR-receptor was required for proper
targeting. Presumably, the overexpression of G-proteins led to satura-
tion of the endogenously expressed receptors, and, hence, affected their
localization.
We tested the latter hypothesis by co-expressing G-proteins and the







-YFP and the CXCR4, respectively. Since
A673 cells exhibit only a low expression of endogenous CXCR4 (Sand et
al., in press), co-expression led to a massive increase of CXCR4 in the
cells. Since all constructs used the same promoter sequence and because
we transfected with identical amounts of DNA, we assumed that similar
amounts of the respective proteins were synthesized.
Confocal imaging confirmed our earlier hypothesis. Co-expression
of the receptor with the G-proteins resulted in a pronounced plasma









stayed cytosolic (Fig. 1B). This
finding corroborates earlier reports in which G
↵
subunits were shown to
appear as both membrane-bound and cytosolic fractions (Bunemann et
al., 2003). The increase in plasma membrane localization with overex-
pression of the receptor further suggests that a fraction of G-proteins
was pre-coupled to their receptor. It is interesting to note that the local-
ization of G
  
was unaltered on co-expression with CXCR4 (Fig. 3.1B).
The latter finding was predicted, given that receptor/G-protein interac-
tion is mediated by G
↵
but not by G
  
(Hamm, 2001).
Subsequently, we examined how activation of CXCR4 would affect
localization of the G-proteins. We applied a continuous global stim-
ulation with 100 nM of its specific ligand CXCL12 during time-lapse
confocal imaging. At the cell perimeter no obvious change in G
↵i
lo-
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Figure 3.1













-YFP with CXCR4. Images were acquired 24 hours after
transfection. Scale bar - 10 µm.
calization was observed. It should be noted that imaging of a specific
response on a short time-scale would require a low cellular background
signal, which is in contradiction with the level of G
↵i
-YFP expression
present in transfection experiments. Hence, we concentrated our further
analysis to the thin membrane protrusions, which extended from the cell
body (Fig. 3.2). At those locations addition of CXCL12 resulted in a
prompt response of G
↵i
subunits. After ⇠5 s of CXCL12 stimulation,
G
↵i
exhibited a strong accumulation in small cluster-like structures seen
as localized increased YFP signals (Fig. 3.2A). The clustering lasted for
20-25 s. The G
↵q
subunit showed a similar accumulation in cluster-like




clustering did not re-occur for at least the following 30 min-
















-YFP (B) or G
  
-YFP (C) with
CXCR4 before (left) and during (middle and right) global stimulation of CXCR4
with 100 nM of CXCL12. Scale bar - 10 µm.
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subunits exhibit a fast short-term response upon CXCR4 receptor ac-
tivation. CXCL12 stimulation did not display a similar effect on the
G
  
subunits during the first seconds of incubation with the ligand (Fig.
3.2C).
In summary, the results showed that activation of CXCR4 is fol-
lowed by a re-localization of the plasma membrane-bound fraction of G-
proteins. Given that the response was fast, on the timescale of seconds,
we in turn hypothesized that a fraction of the G proteins potentially
was pre-coupled to the receptor in order to allow for the fast response
observed.
3.3.2 Mobility of membrane proteins is unaltered on cell-
substrate adhesion
To obtain a deeper insight into the behavior of the membrane-anchored
fraction of G-proteins and learn about the dynamic behavior after cell
stimulation we applied single-molecule fluorescence microscopy. Inas-
much as G-proteins were present in two fractions, a cytoplasmic and
a membrane-anchored fraction, single-molecule experiments required re-
striction of our analysis to the thin (least cytoplasm-containing) parts of
the cell. In this configuration it is experimentally difficult to distinguish
top and bottom membrane of a cell during the single-molecule imaging.
Thus, we used a well-studied control system, CXCR4-YFP in A673 cells
(Chapter 2 of this thesis), to elicit whether membrane interaction with
the surface of the dish would affect the motility of membrane-associated
molecules.
Similar to our previous study (Chapter 2 of this thesis), we accessed
the diffusion dynamics of individual CXCR4-YFP on the millisecond
time-scale as described in Materials and Methods. We detected indi-
vidual CXCR4-YFP with ⇠40 nm localization precision and determined
their mobility on the proximal (bottom) and the distal (top) plasma
membrane.
As reported earlier two fractions of different mobility were observed,
in which one was mobile and the other immobile. The fraction size ↵,
and mean square displacements (MSD) were determined subsequently.
Our results showed that the MSD was indistinguishable between the top
(filled black and red circles) and the bottom (open black and red circles)
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Comparison of CXCR4 mobility at top and bottom part of the plasma membrane. A.
Mean square displacement of mobile (black) and immobile (red) receptors determined
at the top (filled symbols) and bottom (open symbols) membrane of cells placed on
plastic dishes (circles) or on dishes pre-coated with fibronectin (squares). B. Change
of mean square displacement (MSD) with time for mobile (black circles) and immobile
(red open circles) receptors. Data were fit to a free diffusion model (black and red
lines). C. Comparison of the fractions of mobile receptors detected at the top (black)
and bottom (grey) membrane for cells placed on non-treated or fibronectin pre-coated
dishes.
The linear dependence of the mean squared displacement with time
lag confirmed that the mobility for the mobile fraction was described
by free diffusion, characterized by a diffusion coefficient of D
CXCR4 =
0.14±0.01 µm2/s (Fig. 3.3B). The fraction size of the mobile receptors
on top and bottom membranes was identical within error and yielded
⇠80% (Fig. 3.3C). All values were in excellent agreement with the values
reported earlier by us for the distal membrane (Chapter 2 of this thesis).
We further examined whether enhanced cell adhesion would affect
diffusion of the receptors. A673-CXCR4 cells were placed on dishes that
were pre-coated with fibronectin. Interaction of the cells with fibronectin
did not alter the mobility of CXCR4 (Fig. 3.3). Both the diffusion
coefficient (Fig. 3.3A,B) and the size of the mobile fraction (Fig. 3.3C)
resembled those of the control.
Our results demonstrate that membrane interaction with the surface
of the dish did not alter the diffusion dynamics of the trans-membrane
chemokine receptor CXCR4. Hence, it is conceivable that the mobil-
ity of G-proteins, which are only membrane-bound to the inner plasma
membrane leaflet, would be likewise undisturbed. This finding largely


















































































. A. MSD vs. time determined for fast diffusing (black) and im-
mobile (red) G
↵i
molecules in resting A673 cells. B. MSD of fast diffusing (black),
slow diffusing (blue) and immobile (red) molecules for cells stimulated by 100 nM of
CXCL12. The data were globally fitted to a 3-fraction diffusion model. Solid lines
represent the respective fit of the data. C. Time-dependent change of the fraction
sizes of immobile (open red) and fast (black) and slow (blue) diffusing G
↵i
molecules
during continuous stimulation of CXCR4 with 100 nM CXCL12.
simplified further experiments since it did not require the distinction of
the top and bottom membrane in the analysis.
3.3.3 Binding of G
↵i
to CXCR4 requires receptor activa-
tion
Single-molecule imaging was used to study the mobility of individual
membrane-bound G-protein subunits. As anchoring of G-proteins to the
plasma membrane is facilitated through a membrane-binding lipid moi-
ety, which is much smaller compared to the size of the CXCR4 receptor,
one can predict that receptor-decoupled G-proteins were characterized
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by a significantly increased diffusion constant in relation to GPCR-bound
G-proteins.
In resting cells the G
↵i
-subunits existed in two fractions, a mobile
and an immobile fraction (Fig. 3.4A). The mobile fraction of 76±2%,
followed free diffusion characterized by a diffusion coefficient of D
G↵i
=
0.48±0.02 µm2/s. This value was significantly higher than that of the
CXCR4 receptor (D
CXCR4 = 0.14 ± 0.01 µm2/s). Thus, our results
confirmed the prediction made above. For resting cells there was no
detectable fraction of G
↵i
that would exhibit a diffusion behavior similar
to the mobile fraction of the CXCR4. This observation leads to the
conjecture that the mobile fractions of G
↵i
and CXCR4 were not coupled
prior to CXCL12 stimulation.
Next we applied 100 nM of CXCL12 to specifically activate CXCR4
and subsequently monitored changes in the mobility of G
↵i
. Our results
revealed, that there was no significant change in the size of the immo-
bile fraction of G
↵i
, compared to that before stimulation (18±9 % and
24±2 %, respectively). Taken our earlier finding that the fraction of
immobile CXCR4 increased upon activation, this result suggested that
the immobile fraction of the G
↵i
was also independent and not coupled
to the immobile receptors (Chapter 2 of this thesis). Further we found
that the mobile fraction of the G
↵i
-subunits was split into two diffusive
fractions, a fast and a slow fraction (Fig. 3.4B) with diffusion coeffi-
cients D
G↵i(fast) = 1.13±0.02 µm2/s and DG↵i(slow) = 0.25±0.01 µm2/s,
respectively. The diffusion coefficient of the slow fraction was compa-
rable to that of the mobile CXCR4 receptor. This finding implies that
CXCL12 stimulation lead to a physical interaction of G
↵i
and CXCR4,
which lasted at least for 150 ms, the longest time-lag we investigated.
We next followed the value of the mobile fractions of G
↵i
after con-
tinued stimulation with CXCL12 for 30 minutes. On this time scale the
size of the fast fraction (Fig. 3.4C, middle) exhibited a tendency to de-
crease at a rate of ⇠1%min 1. Interestingly, we observed the appearance
of the slow fraction of G
↵i
within the first minutes after CXCL12 addi-
tion exhibiting a tendency to increase at the same rate. This result is
in excellent agreement with earlier findings by FRET that showed the
onset of G
↵i
/receptor coupling on time scale of seconds (Bunemann et
al., 2003).
Thus, our data showed that interaction of G
↵i
with CXCR4 is de-
pendent on and occurs after receptor stimulation, suggesting that G
↵i
/































. A. Mean square displacement (MSD) of fast diffusing (black), con-
fined (blue) and immobile (red) molecules as resulting from a global fit of the resting
and CXCL12 stimulated cells. Solid lines represent the respective fit of the data.
The linear size of the confinement zone yielded L = 1.1±0.1 µm. B. Comparison of
fraction sizes of fast diffusing (black), confined (blue) and immobile (open red) G
↵q
molecules in resting cells or upon CXCR4 activation with 100 nM CXCL12.




is pre-coupled to an inactive CXCR4 receptor







existed in mobile and immobile states in resting
cells. However, already before activation of the receptor, the mobile
fraction of the G
↵q
-subunits was split into 2 populations (Fig. 3.5), a
fast fraction characterized by D
G↵q(fast) = 0.35 ± 0.04 µm2/s and a
slow fraction characterized by D
G↵q(slow) = 0.15 ± 0.02 µm2/s. To our
surprise, the fraction of slow G
↵q
molecules (54±11%) was the dominant
fraction (Fig. 3.5B). Activation of CXCR4 by 100 nM CXCL12 resulted
in a drastic change in G
↵q
fraction sizes (Fig. 3.5B). The fast fraction
increased to 44±5% compared to resting cells (20±14%), while the slow
fraction dropped to 4±3% when compared to the resting state (54±11%).
Moreover, the fraction of immobile G
↵q
-subunits increased from 26±18%
in resting cells to 52±6% in cells with activated CXCR4 receptors (Fig.
3.5B).






peared to be pre-coupled to the CXCR4 receptor in resting cells. Upon
receptor activation G
↵q
subunits either uncouple from CXCR4, as re-
flected in an increase of the fast fraction, or are immobilized. Earlier we
reported a likewise immobilization of CXCR4 upon stimulation that was
related to receptor internalization (Chapter 2 of this thesis), suggesting
that the immobilized G
↵q
fraction might be associated to a receptor/G-
protein complex destined to internalization.
3.4 Discussion
Signalling by the chemokine receptor CXCR4 is a complex process which
includes activation of G-protein dependent and independent pathways
ultimately regulating gene expression, cell proliferation, survival, and
chemotaxis (Teicher and Fricker, 2010). The ensemble of G-protein de-
pendent pathways activated by CXCR4 involves signalling through four
various G
↵
subunits (Rubin, 2008). Thus, the orchestration of all the
signalling cascades in time and space has to be tightly controlled. Here
we investigated the mechanism of CXCR4 interaction with G-proteins
and its relation to the receptor signalling. Our data suggested a sequen-




, which would result in a temporal
ordering of the signalling (Fig. 3.6).
In the inactive state CXCR4 appeared to be coupled to the G
↵q
sub-
unit. This conclusion followed from the detected fraction of G
↵q
that
displayed an identical mobility when compared to the mobility of the
inactive CXCR4. Furthermore, the respective fraction was lost after re-
ceptor activation by CXCL12, implying uncoupling of G
↵q
from the re-
ceptor after activation. It is known that G
↵q
activation leads to a Ca2+
influx through the phospholipase-C  (PLC ) pathway (Rubin, 2008).
The Ca2+ influx is fast, observable from the first moments after recep-
tor activation (Fig. 3.6), indicating immediate triggering of the PLC 
cascade, thus, further supporting our assumption of pre-coupling of G
↵q
to CXCR4.
The release of G
↵q
-subunit from the stimulated receptor subsequently
allows coupling of the G
↵i
-subunit to CXCR4 with concomitant activa-
tion of G
↵i
. This conclusion followed from our mobility analysis, which
suggested that in the inactive state CXCR4 was not coupled with G
↵i
.
Upon CXCR4 stimulation with CXCL12 a receptor-bound fraction of
G
↵i
was observed. This receptor-bound fraction of G
↵i
increased with

























































Schematic representation of the CXCR4 signalling sequence. A. Model of sequential
activation of the G-proteins and respective pathways. B. The time-line (in log scale)
of CXCR4 signalling after CXCL12 stimulation. The slow increase and fast decrease of
Ca2+ flux is detected from the first moments and lasts for ⇠20-30 seconds (Arnolds et
al., 2013; Busillo et al., 2010; Mueller et al., 2013; Sotsios et al., 1999; Tripathi et al.,
2014). A decrease of cAMP concentration is delayed and has a prolongated effect of
⇠30 minutes (Yang et al., 2007). Between ⇠15 seconds and 2 minutes after receptor
activation, an elevated concentration of PIP3 is detected (Sotsios et al., 1999). A
maximum of Akt and Erk phosphorylation is attained 5-10 minutes after stimulation
(Brennecke et al., 2014; Kawaguchi et al., 2009; Sotsios et al., 1999; Torossian et al.,
2014; Wojcechowskyj et al., 2011; Zhao et al., 2006). G-protein independent receptor
internalization is detected as soon as 2 minutes after addition of the ligand (Busillo et
al., 2010; Mueller et al., 2013; Tripathi et al., 2014; Venkatesan, 2003). A maximum
of  -arrestin recruitment appears at 5-10 minutes (Busillo et al., 2010).
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time, suggesting a prolonged activation of G
↵i
. It is known that G
↵i
activation results in a decrease of intracellular cyclic AMP (cAMP) con-
centration through the adenylate cyclase inhibition (Fig. 3.6). This
decrease has been observed with a delay after receptor activation and
has been reported as long lasting (Fig. 3.6) (Yang et al., 2007). Those
earlier biochemical findings were corroborated by our findings based on
protein mobility showing a delayed and prolonged G
↵i
/CXCR4 coupling.




subunits were shown cross-
activate intracellular signalling pathways. Activation of G
↵q/11-coupled
receptors was shown to be crucial for signalling by various G
↵i/o
-coupled
receptors (Bakker et al., 2004). For instance, G
↵q
-stimulated PLC -
activity was increased by G
↵i
-linked receptors (Chan et al., 2000). Hence,




by CXCR4 could be a mecha-
nism to control the activation of specific pathways. One potential sce-
nario would be that receptor activation causes an immediate activation
of the pre-coupled G
↵q
and, thus, of PLC  followed by G
↵q
uncoupling.
The sequential and prolonged interaction of CXCR4 with G
↵i
, in turn
would further promote PLC  signalling. Inasmuch as the PLC -pathway
is associated with the chemotactic response (Teicher and Fricker, 2010)
such a signalling control and amplification mechanism might be involved
in the initial steps of the gradient sensing.
In summary, our results showed that the chemokine receptor CXCR4
has a differential coupling with various G
↵
-subunits. The coupling with
G
↵q
corresponds to ‘pre-coupled’ model, while coupling with G
↵i
follows
‘collision coupling’ model. Such difference in the coupling appears to
be a mechanism of controlling the subsequent activation of respective
pathways and, thus, an important mechanism to specific CXCR4 signal
transduction.
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G-protein coupled receptors (GPCR) occupy ⇠3% of the human
genome and represent a key target of the pharmaceutical market. Despite
extensive development of biochemical and biophysical assays devoted to
GPCR research, the development of new tools allowing achievement of
a precise temporal and spatial control on the experimental system is re-
quired. Here we describe the application of the emergent high-potential
research tool of optogenetics as a tool to study GPCRs. Optogenetics is
based on a combination of genetic targeting and optical stimulation. We
describe in detail the steps for the design and the cloning of a chimeric
protein consisting of a light-activated GPCR, rhodopsin, and a chemokine
receptor, CXCR4. We show that the chimeric receptor optoCXCR4 ex-
hibits plasma membrane localization under appropriate conditions. Here
we made the first steps in the development of a chimeric receptor, which
could be used for further detailed investigation of CXCR4 signalling with
high temporal and spatial resolution. Further developments are required




More than 800 genes in the human genome are encoding for transmem-
brane G-protein coupled receptors (GPCRs) (Fredriksson et al., 2003).
With this number, GPCRs represent the largest family of membrane pro-
teins. Members of this family induce a wide variety of cellular functions,
among which neurotransmission, blood pressure regulation, heart-rate
regulation, and immune response, making this protein family the largest
target of modern drugs. Almost half of all prescribed drugs today target
GPCRs (Wess et al., 2008).
Phylogenetic analysis revealed that the GPCR family is divided into
5 sub-families as to their main physiological outcome: the adhesion
family regulating tissue integrity; the secretin family controlling hor-
mone response; the glutamate family important in neurotransmission;
the frizzeled family important for embryo development; and the rhodopsin
family which includes receptors for vision (Fredriksson et al., 2003). The
rhodopsin family, which encompasses a wide variety of functionality, con-
stitutes by far the largest sub-family (701 receptor) forming 4 groups:
↵,  ,  ,  . The  -group of rhodopsin receptors includes the chemokine
receptor cluster (Fredriksson et al., 2003). Chemokine receptors are re-
ceptors to small peptide molecules, chemokines, which are released in the
body to pass information on long length scales. Activation of chemokine
receptors is a key to directional cell migration called chemotaxis. Chemo-
taxis is essential for multiple physiological and pathological processes
like embryogenesis, immune response, angiogenesis, inflammation, and
metastasis.
Given their central role in inflammation and metastasis, chemokine
receptors acquired quite some scientific interest. Activation of the chemo-
kine receptors propagates biochemical reactions causing membrane pro-
trusion formation towards higher concentrations (gradient) of the ligand.
Subsequent cellular movement ultimately results in directional cell mi-
gration toward the source of ligand expression. Several models of gra-
dient sensing were proposed. However, the direction recognition mech-
anism by chemokine receptors is still a topic of debate. One of the
experimental challenges in the study of chemokine receptor functionality
in a life cell setting is the application of precisely timed, well controlled
(in terms of concentration, steepness, direction, and location) and stable
chemical gradients.
Initially such chemical gradients were produced by micropipettes
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filled with the chemoattractant. Although well-defined gradients could
be obtained in such a way, gradients were stable only for a limited time
and could be modulated only at limited frequencies. Moreover, exper-
iments required a significant amount of material, which frequently ren-
dered such experiments unreasonable. The development of microfluidic
devices allowed the creation of long-time stable gradients which, de-
pending on design, made high-frequency chemical modulation possible.
Further, the microfluidic approach required only a minimum of mate-
rial. However, compared to the earlier micropipette experiments, the
microfluidics approach comprised a major disadvantage. The direction
of the chemical gradient is predefined by design prior to the experiment
and a gradual change in gradient direction with time is essentially im-
possible.
Both techniques generate gradients that extend at least on the size
of a cell. Although this might reflect the situation in vivo, for some ex-
perimental designs it would be advantageous to apply a very localized
chemical signal to cells, which in turn would yield a better understand-
ing of the cytosolic signal-propagation characteristics. One approach for
local cell stimulation is based on the use of chemokine-carrying beads
that locally release signals when brought into contact with the cell. The
position of the beads is controlled by electric or magnetic fields or by op-
tical beams resulting in a high precision and high frequency possibility
to challenge cellular response. Although this approach has been suc-
cessfully applied and has become widely accessible, it adds a substantial
complication to the experimental procedure.
In this current report we describe yet another approach which is
based on an all-optical control of the receptor activity. We followed an
optogenetic approach that has attracted much attention since the first
demonstration of optical-switchable ion channels in 2003 (Nagel et al.,
2003). Optogenetics is now used for targeted control of whole animals
(Arenkiel et al., 2006). Through a combination of genetic targeting and
optical stimulation the optogenetic approach provides a precise temporal
and spatial control on the experimental system (Mattis et al., 2012).
Optogenetics is currently emerging as a new, high-potential research field
(Rein and Deussing, 2012; Tye and Deisseroth, 2012).
Here we developed a chimeric receptor, optoCXCR4, which was light-
activated and allowed us to stimulate cellular response at high spatial
and temporal resolution. Base to our chimeric receptor design is the
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high structural similarity of the chemokine receptors with the compre-
hensively studied rhodopsin receptor. The basic concept for the design
of our optoCXCR4 construct was the replacement of all intracellular
parts of the rhodopsin receptor with those of the chemokine receptor
CXCR4. This approach has been shown feasible earlier for the ↵1- and
 2-adregeneric receptors (Airan et al., 2009). In this way receptor acti-
vation is analogous to that of rhodopsin, hence by light, whereas the in-
tracellular signalling is controlled by the inner loops originating from the
chemokine receptor of interest. The sequence design of various chimeric
proteins is described in detail, followed by experiments for the character-
ization of their localization targeting properties and functionality. One
of the chimeric receptors produced in the current study was shown to
translocate successfully to the plasma membrane and display some func-
tionality. Hence, we successfully applied an optogenetics approach to
create a novel all-optical controlled chemokine receptor suitable for fur-
ther biophysical studies. Whether the well-defined spatial and temporal
activation of chemokine receptors in the studies of health and disease
can be tackled by such optogenetic approach still has to be explored.
4.2 Materials and Methods
4.2.1 Cell culture
HEK (human embryonic kidney) 293 cells were cultivated in Dulbecco’s
Modified Eagle Medium (DMEM) (Sigma Life Science, USA) supple-
mented with 10% HyClone ™Fetal Bovine Serum (FBS, Thermo Sci-
entific, USA), 1 mL penicillin/streptomycin (10 µg/mL antibiotics and
5 mL Glutamax™(Gibco, USA). Cells were cultured on 60 mm dishes.
SH-SY5Y (human neuroblastoma) cells were cultivated in DMEM with
Nutrient Mixture F-12 (DMEM/F12) supplemented with 10% FBS. Cells
were cultured on T25 mattresses.
4.2.2 Sequences alignments
The protein sequence for bovine rhodopsin and CXCR4 were obtained
using the Entrez databases of the National Center for Biotechnology
Information (NCBI, USA). The sequence for opto- 2AR was obtained
from (Airan et al., 2009). Sequence alignments were performed using
the BLAST algorithm (NCBI) or aligned manually.
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4.2.3 Whole-plasmid cloning
The base-construct optoCXCR4 was modified at N- and C-terminus us-
ing a whole-plasmid cloning strategy. 20 ng of the base-construct DNA
was mixed with 10 µM of forward and 10 µM of reverse primers, dNTPs,
polymerase buffer, 20% DMSO and supplemented with MiliQ-water to a
volume of 50 µL. Subsequently 0.25 µL of PfuX polymerase was added
to run the PCR reaction. The entire plasmid was amplified in 25 cy-
cles at a pace of 1.5 min/kB. The mixture was then incubated with 1
µL of DpnI for 1.5 hours to digest the base-construct DNA, followed by
digestion with the relevant restriction enzyme (Supplemental Fig. S1
and S2) for 2 hours and ligation for 3 hours. Competent bacteria cells
were transformed with the plasmid or its non-ligated analogue as control.
Successful colonies were collected for amplification. DNA was purified
using the DNA-purification kit following the manufacturers protocol and
subsequently sequenced to check for correct sequence and/or point mu-
tations (LGC Genomics or BaseClear).
4.2.4 Cell transfection
For experimental procedures ⇠105 cells were seeded in full medium on
35 mm dishes coated with ibiTreat (Ibidi, Germany) and incubated
overnight prior to transfection. HEK 293 cells were transfected using
specific ratios of FuGene HD (Promega Corporation, USA) or Turbo-
Fect (Thermo Scientific, USA) and the plasmid DNA, mixed in DMEM
or OptiMEM (Life Technologies, USA). Before transfection, the medium
was changed to 1 mL of corresponding serum-free medium. Then 100 µL
transfection mixture was added. After the specified incubation time with
the transfection mixture the medium was changed back to full medium.
The cells were incubated overnight to allow for the protein expression.
SH-SY5Y cells were transfected as described above, with the following
modifications: the cell medium was changed to full medium approxi-
mately 6 hours before transfection, then transfection mixture was added.
The cells were incubated overnight with the transfection mixtures. After
incubation, the medium was changed to fresh DMEM/F12.
4.2.5 Microscopy
Imaging was performed on an Axiovert200 microscope (Zeiss, Germany)
combined with a spinning disk unit (CSU-X1; Yokogawa, Japan) and
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emCCD camera (iXon 897; Andor, UK). For illumination 514 (Cobolt)
or 561 (Cobolt) nm lasers were used. Where indicated the CO2 level was
maintained at 5% and the temperature at 37 C using a microscopre-top
unit (INUBG2E-ZILCS, TokaiHit, Japan).
4.2.6 Dual reporter activity assay
HEK 293 cells were co-transfected with the reporter element fused to
the firefly luciferase (RE-luc), Renilla and one of the test sequences. We
used a transfection mixture of plasmid DNA and Lipofectomine diluted
separately in 12.5 µL of opti-MEM medium (Sigma Life Science, USA).
Premixed components were incubated together for 20 minutes and added
to the cells. After overnight incubation cells were supplemented with 100
nM of 9-cis retinal followed by 16 hours incubation. Cell activation was
performed inside an incubator that was equipped with 502 nm LED il-
lumination of uniform intensity of 200 µW/cm2 for 6 hours. For the
control (non-transfected sample) and for the sample transfected with
CXCR4 (wt), activation was achieved by the addition of 100 nM of the
CXCR4-specific ligand CXCL12. Subsequently the dual-luciferase detec-
tion was performed as described by the manufacturer. Briefly, cells were
incubated for 15 min with luciferase assay reagent II (Promega) after
which the luminescence signal was detected. Then, the cells were sup-
plemented with Stop&Go®Reagent (Promega), which simultaneously
quenches firefly luminescence and activates Renilla luciferase. After 15
min incubation Renilla luminescence was measured. The firefly lumines-
cence was normalized to the luminescence of Renilla, in order to eliminate
artefacts caused by, e.g. a difference in the number of cells in the sam-
ple. Further the average signals of activated samples was normalized to
the average signal of non-activated samples. As negative control, sam-
ples transfected with RE-luc and Renilla only were used. All data are
presented as mean of 2 to 5 independent experiments and the spread as
standard deviation.
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4.3 Design and characterization of an optoCXCR4
receptor
4.3.1 Design of optoCXCR4
Rhodopsin is the most extensively studied G-protein coupled receptor
(GPCR). It was discovered in 1851 (Costanzi et al., 2009) and in 1970
identified as GPCR (Costanzi et al., 2009). In 1982 the receptor was
sequenced (Costanzi et al., 2009) which revealed its 7-transmembrane
(TM) topology. In 2000 rhodopsin was the first membrane protein for
which the X-ray crystal structure was obtained (Palczewski et al., 2000).
Due to the sequence homology of the rhodopsin sub-family of GPCRs
the resolved crystal structure of rhodopsin served as a base for the struc-
ture of other GPCRs of this family. The structure of a GPCR consists
of three parts: (1) the extracellular, (2) the transmembrane and (3) the
intracellular part (Fig. 4.1A). The extracellular part includes the N-
terminus and three extracellular loops (EL1-EL3) together responsible
for modulation of ligand access and ligand specificity. The transmem-
brane part consists of seven ↵-helices (TM1-TM7), forming the structural
core of the receptor. The helices of the TM region are responsible for
ligand recognition and signal transduction (Rajagopalan and Rajarath-
nam, 2006; Rosenkilde et al., 2000). The intracellular region includes
intracellular loops (IL1-IL3), a small amphipathic helix (H8) and C-
terminus. The intracellular parts determine downstream signalling via
its G-protein binding sites on IL3 and the modulation of receptor activity
on its C-terminal responsible for receptor downregulation and internal-
ization (Venkatakrishnan et al., 2013). Thus, the TM region is thought
of as communication link between the ligand-binding pocket and the G-
protein-coupling region (Venkatakrishnan et al., 2013). The activation
of the receptor results in its structural change. Multiple biochemical
and biophysical studies suggested a common model of the TM helixes
movements (Hoffmann et al., 2008; Venkatakrishnan et al., 2013; Wess
et al., 2008). Mainly the TM helix 6 undergoes the largest movement
(Hoffmann et al., 2008; Wess et al., 2008) inducing a rotational move-
ment leading to a concomitant shift of the intracellular loop 3 (IL3) that
controls the G-protein interaction and reorientation of its cytoplasmic
end.
In contrast to all other GPCRs in which the ligand binds to the N-
terminal part followed by interaction with the TM part, in rhodopsin
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Bovine rhodopsin MNGTEGPNFYVP--FSNKTGVVRSPFEAPQYYLAEPWQFS--MLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYI 
Human CXCR4       ---MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKY 
OptoCXCR4  MNGTEGPNFYVP--FSNATGVVRSPFEYPQYYLAEPWQFS--MLAAYMFLLIVLGFPINFLTLYVMGYQKKLRSMLNYI 
Opto-b2AR  MNGTEGPNFYVP--FSNKTGVVRSPFEAPQYYLAEPWQFS--MLAAYMFLLIMLGFPINFLTLYVIAKFERLQTVLNYI 
 
 
Bovine rhodopsin LLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENH- 
Human CXCR4       RLHLSVADLLFVIT--LPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLL- 
OptoCXCR4  LLNLAVADLFMVLGGFTSTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVVHATNSQRPRKlL- 
Opto-b2AR  LLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVTSPFKYQSLLTKNK 
 
 
Bovine rhodopsin AIMGVAF-TWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTV 
Human CXCR4       AEKVVYVGVWIPALLLTIPDFIFAN--VSEADDRYICDRFYP--NDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKL 
OptoCXCR4  AIMGVAF-TWVMALACAAPPLAGWSRYIPEGLQCSCGIDYYTLKPEVNNESFVIYMFVVHFTIPMIIIFFCYGIIISKL 
Opto-b2AR  AIMGVAF-TWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGR-VFQV 
 
 
Bovine rhodopsin KEAAAQQQE--------------------------SATTQKAEKEVTRMVIIMVIAFLICWLPYAG------VAFYIFT 
Human CXCR4       SHSKGH-QKR----------------------------------KALKTTVILILAFFACWLPYYIGISIDSFILLEII 
OptoCXCR4  SHSKGH-QKR----------------------------------KALRMVIIMVIAFLICWVPYAS------VAFYIFT 
Opto-b2AR  AKRQLQKIDKSEGRFHSPNLGQVEQDGRSGHGLRRSSKFCLKEHKALRMVIIMVIAFLICWLPYAG------VAFYIFT 
 
 
Bovine rhodopsin HQGSDFG---PIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTLCCGKNPLGDDEASTTVSKTETSQVAPA 
Human CXCR4       KQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS 
OptoCXCR4  HQGSNFG---PIFMTIPAFFAKSAAIYNPVIYIMMNKQFRTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS 
Opto-b2AR  HQGSDFG---PIFMTIPAFFAKTSAVYNPVIYIMMNKQFRIAFQELLCLRRSSSKAYGNGYSSNSNGKTDYMGEASGCQLGQ 
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Figure 4.1
Design of the chimeric protein. A. Schematic of the GPCR structure contain-
ing N-terminal, extracellular loops (EL1-EL3), transmembrane helixes (TM1-TM7),
intracellular loops (IL1-IL3) and C-terminal. B. Schematic representation of the
chimeric protein design. The IL of rhodopsin are exchanged with the IL of the GPCR
of interest. The resulting chimeric receptor exhibit signalling of GPCR of interest
when triggered by light activation (h⌫). C. Alignment of the bovine rhodopsin with
human CXCR4 for construction of photo-activatable chimeric protein - optoCXCR4,
compared to opto- 2AR (Airan et al., 2009) .
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the ligand (retinal) is bound to the receptor though Lys296 (TM7) in
the inactive state of the receptor. On light absorption an isomerization
of retinal occurs and subsequently triggers a series of conformational
changes including the rotation of TM6 leading to the G-protein activation
(for review see Hofmann et al., 2009).
The high structural similarities of GPCRs including their activation
scheme allowed the application of an optogenetic approach to GPCRs. It
is assumed, that the precise output signal of the receptor is controlled pri-
marily by the intracellular parts of the GPCR. Receptor activation, how-
ever, is controlled by the TM regions where the conformational change
is translated into a structural change of the intracellular regions. The
latter subsequently leads to the activation of G-protein dependent and




↵q/11, G↵s or G↵12/13 and G  ), while the
C-terminal part of the GPCR is responsible for recognition of receptor
kinases, which regulate a balanced receptor trafficking. Hence, a strategy
was developed to exchange all intracellular parts and C-terminal of the
rhodopsin receptor with that of another GPCR to produce a chimeric
protein of particular functionality being controlled by light (Fig. 4.1B).
Kim et al. in 2005 demonstrated the feasibility of this approach with
the first design of a functional all-optically activated GPCR (Kim et
al., 2005). The group showed that exchange of the intracellular loops
and the carboxyl (C)-terminal domain of rhodopsin with those of the  2
adrenergic receptor ( 22AR) results in a chimeric receptor, opto- 2AR,
which exhibited full  2AR functionality but was light-activated. Further
this chimeric-receptor approach has been demonstrated to be successful
for creation of functional ↵1-adregeneric receptor as well (Airan et al.,
2009).
4.3.2 Cloning of various optoCXCR4 constructs
Here we designed various rhodopsin-CXCR4 chimeras following the strat-
egy described by Kim et al. In the decision for the exact exchange posi-
tions of intracellular loops and C-terminus we were led by the alignment
of the nucleotide sequence to that of rhodopsin and CXCR4, superposi-
tion of crystal structure of rhodopsin with recent crystal structure of the
CXCR4 receptor (Wu et al., 2010), and by an earlier study (Xu et al.,
2014). We used these findings to design an optically activated CXCR4
receptor - optoCXCR4.




































Design of enhanced optoCXCR4 plasmids. A. Schematic representation of the addi-
tion of the C-terminus amino acids of rhodopsin -TETSQVAPA (dark blue), and the
influenza SP - VSV g-epitope (yellow) to optoCXCR4-mCherry (light blue - pink).
B. Amino-acid sequence of the final optoCXCR4-TETSQVAPA-mCherry plasmid.
C. Amino-acid sequence of the final inflSP_VSVG-optoCXCR4-mCherry (top) and
inflSP_VSVG-optoCXCR4-TETSQVAPA-mCherry (bottom) plasmids.
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In our base-design the intracellular loops and the C-terminus of the
chimeric receptor were identical to those of human CXCR4, the rest was
equal to that of rhodopsin (Fig. 4.2B,C). The rhodopsin intracellular
loop IL1 (V61-I75) was replaced starting from T62 with IL1 of CXCR4
(M63-M72). Similarly, IL2 of rhodopsin (Y135-H151) was replaced starting
from C139 with IL2 of CXCR4 (V139-L151). Rhodopsin-IL3 (Q224-R251)
was completely replaced with IL3 of CXCR4 (I221-L239). Finally, the
C-terminal part of rhodopsin was exchanged five amino acids after TM7
(N309-R314) with the C-terminal part of CXCR4 (T311-S352). Further-
more, at the C-terminus the construct was fused to either of the fluo-
rescent proteins YFP or mCherry to enable visualization of the chimeric
receptor. This base-design for an optoCXCR4 containing 355 amino
acids was translated into a DNA sequence optimized for mammalian ex-
pression, synthesized (Genscript) and cloned into the pUC57 plasmid
vector (Invitrogen). For further application we subsequently re-cloned
the construct into the pcDNA3.1(+)-eYFP C1 vector.
Additionally to the base-construct we designed other constructs with
modifications to the N- and C-terminus in order to putatively facilitate
protein trafficking and assist proper protein targeting (Fig. 4.2).
To facilitate protein trafficking the last 9 amino-acids of the C-terminal
domain of rhodopsin (TETSQVAPA) were added to the C-terminal of
the base-construct. The QVS(A)PA amino-acid sequence is highly con-
served for various opsins and shown to play an essential role in the for-
mation of post-Golgi vesicles (Deretic, 1998; Deretic et al., 1998). Mu-
tations in the C-terminal region of rhodopsin caused mislocalization of
the protein (Deretic, 1998). To introduce the C-terminal sequence of
rhodopsin (TETSQVAPA) a cloning technique based on PCR multipli-
cation of the entire plasmid was used. We designed primers with homolo-
gous sequences to optoCXCR4-mCherry and the TETSQVAPA sequence
as shown in the Supplementary Fig. S1. The whole-plasmid cloning pro-
cedure was performed as detailed in the Materials and Methods section.
The final amino-acid sequence of optoCXCR4-TETSQVAPA-mCherry
(further referred to as optoCXCR4-C9) is shown in Fig. 4.2B.
Further, we added a signalling peptide to the N-terminus of the base-
construct to assist proper protein targeting towards the plasma mem-
brane. It has been demonstrated that a N-terminal signalling peptide
is required for receptor translocation across the endoplasmic reticulum
(ER). GPCRs lacking this signalling peptide were retained in the ER
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in a non-functional form (Kochl et al., 2002). As a N-terminal sig-
nalling motif we used an epitope of the vesicular stomatitis virus-G
protein (VSVG) followed by the influenza A signalling peptide (inflSP).
VSVG is a trans-membrane glycoprotein that contains a six amino acid
signalling sequence facilitating efficient export of the protein from the
endoplasmatic reticulum (ER). VSVG enhances viral envelope fusion
with the plasma membrane (Roche et al., 2008). The six-residue epi-
tope was shown to be sufficient for enhanced ER export (Sevier et al.,
2000). For cloning the whole-plasmid strategy was used. Given that
the inflSP-VSVG sequence was too long to be coded into one primer, a
silent mutation was introduced in the middle of the sequence to create
a restriction site (Supplementary Fig. S2). That allowed us to incor-
porate inflSP-VSVG in such a way, that one part was included in for-
ward and the other in reverse primer. Using optoCXCR4-mCherry and
optoCXCR4-TETSQVAPA-mCherry as base-construct DNA, we gener-
ated inflSP_VSVG-optoCXCR4-TETSQVAPA-mCherry and
inflSP_VSVG-optoCXCR4-mCherry plasmids (further referred to as v-
optoCXCR4-C9 and v-optoCXCR4, respectively) encoding the desired
inflSP_VSVG sequence with or without the TETSQVAPA sequence
(Fig. 4.2C).
In total five plasmids were created including the base-construct op-
toCXCR4: optoCXCR4-YFP, optoCXCR4-mCherry, optoCXCR4-C9,
v-optoCXCR4 and, v-optoCXCR4-C9.
4.3.3 Optimization of cell transfection
Human embryonic kidney HEK 293 cells have a substantial endogenous
expression of CXCR4. Thus, this cell line appeared as an appropriate
system to follow optoCXCR4 signalling. We first optimized the transfec-
tion conditions for HEK 293 cells with the optoCXCR4 constructs using
two different transfection reagents: FuGene and TurboFect. For trans-
fections with FuGene 6 to 20 µL of reagent was mixed with 0.5-2 µg of
plasmid DNA resulting in reagent:DNA ratios of 3:1, 6:1, 10:1 and 12:1.
The incubation time with the FuGene-based transfection mixtures was
kept at 3 hours. For transfections with TurboFect, 1-4 µL of the reagent
were mixed with 1 µg of plasmid DNA resulting in reagent:DNA ratios
of 1:1, 2:1 and 4:1. T he incubation time for TuboFect-based transfec-
tion mixtures ranged from 0.5-2 hours. We found that using 4 µL of
TurboFect, 1 µg of DNA and 1.5 hours of incubation time led to optimal
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Transfection with optoCXCR4. A. HEK 293 cells transfected with optoCXCR4-
YFP using 1.5 hours of incubation with a transfection mixture containing 4 µL of
TurboFect and 1 µg of DNA. B. HEK 293 cells transfected with optoCXCR4-mCherry
using same transfection protocol after 1 (left) or 3 (right) days of expression. C. HEK
293 cells transfected with different variants of optoCXCR4-mCherry plasmid. Scale
bar - 10 µm.
transfection condition. the transfection efficiency was estimated from
the percentage of fluorescent cells, 30-50% (data not shown). Hence,
this transfection protocol was used for all further experiments on HEK
293 cells with optoCXCR4, if not indicated otherwise.
4.3.4 Localization of the chimeric receptors
To check the localization of the chimeric protein we performed fluores-
cence imaging on transfected HEK 293 cells. Imaging was done using
spinning-disk confocal microscopy with 514 nm and 561 nm laser excita-
tion for YFP- and mCherry-fused constructs, respectively. As shown
in Figure 4.3 the chimeric proteins did not exhibit any pronounced
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Figure 4.4
Localization of retinal-supplemented optoCXCR4-YFP. A. SH-YSY5 cells transfected
with optoCXCR4. B. HEK 293 cells transfected with optoCXCR4-mCherry plasmid
after overnight incubation with 100 nM 9-cis retinal. Scale bar - 10 µm.
plasma membrane localization. The fluorescent signals indicated that
the optoCXCR4-YFP protein was uniformly distributed throughout the
cell (Fig. 4.3A) and the optoCXCR4-mCherry protein presumably local-
ized in vesicular structures (Fig. 4.3B, left). A longer incubation time
after transfection did not change the localization of the optoCXCR4
constructs (Fig. 4.3B, right). Surprisingly, vesicular localization was
observed for optoCXCR4-C9, v-optoCXCR4 and v-optoCXCR4-C9 con-
structs that were expected to exhibit enhanced plasma membrane tar-
geting (Fig. 4.3C).
To avoid receptor activation during imaging the experiments de-
scribed in Figure 4.3 were performed without addition of retinal, the
rhodopsin ligand. Since it is unclear whether HEK 293 cells produced
retinal endogenously, we questioned whether lack of the ligand might
cause a disruption in the protein folding or protein targeting. Hence,
we repeated the experiments in the neuroblastoma-derived cell line, SH-
YSY5, which was shown to express both receptors CXCR4 and rhodopsin
endogenously (Liberman et al., 2012; Saliba et al., 2002), and supposedly
also produced the retinal. SH-YSY5 cells were transfected as described
in Materials and Methods section. Confocal imaging of transfected SH-
YSY5 cells was performed after overnight incubation. However, similar
to our findings in HEK 293, optoCXCR4-YFP did not show any pro-
nounced plasma membrane localization (Fig. 4.4A). Likewise, overnight
incubation of HEK 293 cells with 100 nM of 9-cis retinal did not alter
the localization of the chimeric receptor (Fig. 4.4B). Hence, the mislo-
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Luciferase assay. A. Schematic representation of the luciferase assay adopted from
Promega (Literature # TM040). B. Relative increase of the luciferase luminescence
detected in HEK 293 cells for different constructs.
calization of optoCXCR4 could not be attributed to the absence of the
ligand.
Another potential reason for the mislocalization of the optoCXCX4
constructs could be due to receptor activation and initiation of the G-
protein signalling cascade followed by a fast internalization of the recep-
tor. Hence, the vesicular localization could potentially be attributed to
the functionality of the receptor.
4.3.5 Functionality of the optoCXCR4 constructs
We tested the various optoCXCR4 constructs for functionality by ana-
lysing the G-protein activity using a dual-reporter luciferase assay (for
details see Materials and Methods). HEK 293 cells were co-transfected
with one of the optoCXCR4 constructs together with a reporter luciferase
(Re-luc) and a Renilla luciferase construct. The Re-luc construct con-
tains the firefly luciferase gene placed downstream of G-protein specific
response elements (REs) (Fig. 4.5A). Stimulation of the receptor results
in activation of a specific G-protein. In turn, the downstream biochemi-
cal cascade triggers the respective transcription factors that bind to the
REs leading to luciferase expression. Luminescence of the Renilla lu-
ciferase was used to normalize the Re-luc luminescence for each sample.
4.3 Design and characterization of an optoCXCR4 receptor103
For our experiments the G
↵i
/G
↵12-RE was used. Figure 4.5B shows
the increase of relative luciferase luminescence for the various
optoCXCR4 constructs after light stimulation. Cells transfected with
the CXCR4 (wt) construct stimulated by 100 nM CXCL12 were used as
a positive control. All data are presented as the relative change in the
luciferase luminescence after stimulation with respect to the luciferase lu-
minescence for non-stimulated cells. As negative control, light-activated
cells transfected with Re-luc and Renilla but without any optoCXCR4
construct were used.
As expected, cells that contain either endogenous CXCR4 or that
were transfected with a CXCR4 (wt) construct exhibited a relative lu-
ciferase luminescence increase of 1.2±0.2 and 1.6±0.4 after stimulation
with CXCL12, respectively. Light activation of the optoCXCR4 and
optoCXCR4-C9 constructs resulted in a relative luciferase increase of
1.1±0.1 and 1.2±0.2, respectively. The v-optoCXCR4 and v-optoCXCR4-
C9 constructs exhibited a relative luminescence change of 0.9±0.1 and
1.0±0.1, respectively. Hence, within error-bars the activity of all op-
toCXCR4 constructs were not different to that of the negative control
cells (1.1±0.2).
The negative results should not be taken as conclusive. In prepa-
ration of the dual-reporter assay cells were frequently exposed to light,
which presumably leads to fast internalization of the chimeric receptors,
and concomitantly to the inability to activate the G-protein pathways.
4.3.6 Fast optoCXCR4 internalization
Many GPCRs are known to undergo internalization upon continued ac-
tivation. The internalization process in GPCRs is related to cellular
adaptation, which allows cells to properly function in a wide concen-
tration range of the ligand. We (Chapter 2 of this thesis), and others
(Venkatesan, 2003) have reported that CXCR4 is efficiently internalized
after stimulation with its natural ligand CXCL12.
Stimulation of rhodopsin by light is an extremely efficient process.
The absorption of a single photon in the range between 400 and 600 nm
suffices for receptor activation. In the experiments described above, we
assumed that optoCXCR4 was inactive when it was not loaded with 9-cis
retinal. However, any presence of retinal in the culture medium or plausi-
ble endogenous production of retinal in HEK 293 cells could not be com-
pletely excluded. Hence, we performed an experiment in complete dark-
104 Construction of optoCXCR4
Figure 4.6
Transfection with optoCXCR4-mCherry. HEK 293 cells imaged 12 hours after trans-
fection with optoCXCR4-mCherry plasmid. Extra precaution was taken to keep the
cells in dark during the whole experimental procedure. Scale bar - 10 µm.
ness and limited the subsequent imaging time to 20 minutes. HEK 293
cells where transfected and incubated in a light-protected microscope-
top incubator at 5% CO2 and 37 C (INCUBG2E-ZILS, Tokai Hit). Af-
ter 12 hours the cells were imaged without additional steps. Following
this transfection procedure resulted in localization of the optoCXCR4-
mCherry largely at the plasma membrane (Fig. 4.6). This result im-
plies that the cytosolic localization of the optoCXCR4 constructs in the
earlier experiments was related to receptor internalization. Hence, the
continued receptor stimulation during experiment preparation led to the
receptor internalization and loss of the plasma membrane localization.
4.4 Conclusions
Here we described the construction of an all-optical controllable chemoki-
ne G-protein coupled receptor optoCXCR4. Inasmuch as the activation
of rhodopsin is extremely fast and efficient, the optoCXCR4 protein was
destined for internalization shortly after activation. A functional and cor-
rectly localized chimeric receptor was only observed when all preparatory
steps were performed in complete darkness. A successful application of
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optogenetic approach to GPCRs in cell-based or whole animal experi-
ments have been shown by various groups. Nevertheless, it appears that
further development is required to optimize this promising research tool
for biophysical studies on GPCR dynamics at high special and temporal
control. One way might be to make a design based on color opsins, which
have a narrower excitation band, making imaging without receptor ac-
tivation more feasible. Another way might include the use of bistable
pigments. The bistable pigments can convert isomerized retinal into
the pre-activated state: they contain an intrinsic bleach-recovery system
and, thus, are capable of repeated activation of the receptor. (Bailes et
al., 2012; Tsukamoto and Terakita, 2010)
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4.5 Supplemental figures
 
Forward primer:  
 
































Design of primers for TETSQVAPA cloning. The forward primer contains a start-
ing sequence, specific restriction enzyme AgeI (green), linker sequence and sequence
homologues to the base-construct DNA. The reverse primer contains a starting se-
quence, specific restriction enzyme AgeI (green), TETSQAPA sequence and sequence
homologues to the base-construct DNA. Start codon and spot codon are colored red,
the sequence of CXCR4 highlighted in blue, the sequence of mCherry - in pink.
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Design of primers for inflSP_VSVG cloning. A silent mutation is inserted at
GATATA sequence. The forward primer contains a starting sequence, specific re-
striction enzyme EcoRV (green), part of inflSP_VSVG (yellow) and sequence homo-
logues to the base-construct DNA. The reverse primer contains a starting sequence,
specific restriction enzyme EcoRV (green), second part of inflSP_VSVG (yellow) and
sequence homologues to the base-construct DNA. Start codon and spot codon are
colored red, the sequence of CXCR4 highlighted in blue, the sequence of mCherry -
in pink.
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Chapter 5
The mechanical phenotype of
Ewing sarcoma cell lines
predicts their metastatic
niche1
1This chapter is based on: E. Beletkaia, O. Iendaltseva, H. E. Balcioglu, P. C.W.
Hogendoorn, E. H.J. Danen, T. Schmidt, The mechanical phenotype of Ewing sar-
coma cell lines predicts their metastatic niche (in preparation)
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Ewing sarcoma develops mostly in bone and lest often in the somatic
soft tissues and their primary site of metastasis are the lungs. Thus,
the mechanical micro-environment of the primary tumor and that of the
metastasis site is drastically different. The stiffness of the lungs (⇠2 kPa)
is about 50 times lower as compared to the stiffness of bone tissue ( 100
kPa). It was shown earlier that the expression of the Ewing sarcoma-
defining chimeric protein EWS/FLI has a dramatic effect on the cellular
architecture, the development of actin stress fibers, and the formation of
cell-matrix adhesions. Here we address the question whether distinct re-
sponses to mechanical cues may impact guidance of Ewing sarcoma cells
towards their site of metastasis. We show that Ewing sarcoma cells have
a preference to soft substrates in two- and three-dimensional assays. In
soft 3D gels cells exhibit an elevated migratory phenotype together with
a more spread morphology, and on softer 2D surfaces an enhanced for-
mation of stress fibers and cell-matrix adhesions. Our data suggest that
the mechanical phenotype of Ewing sarcoma cells is micro-environment
dependent and may impact on the metastatic profile of Ewing sarcoma.
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5.1 Introduction
Ewing sarcoma (ES) is a highly malignant tumor affecting predominantly
children and young adults. ES belongs to a family of small-blue-round-
cell tumors. It develops within bone and at later age sometimes in soft
tissues, with lungs as the primary site of metastasis. Genetically ES is
defined by a chromosomal translocation t(11;22)(q24;q12) (Kovar, 2005;
Sand et al., 2015). This translocation leads to fusion of a portion of
the EWS gene to the transcription factor-like gene EST, mostly FLI1
(Kovar, 2005). The resulting EWS/FLI chimeric protein has no de-
scribed putative enzymatic activity (Erkizan et al., 2010). EWS/FLI
acts as transcriptional factor (Kovar, 2005) causing changes in the ex-
pression of multiple genes including the chemokine receptor 4 (CXCR4)
(Bennani-Baiti et al., 2010). It is believed that up-regulation of CXCR4
is a hallmark in alteration of cell behavior and potentially promotes ES
metastasis. Overexpression of CXCR4 leads to enhanced directional cell
migration towards the sites of tissue where it,s chemokine ligand CXCL12
(stromal-derived factor 1, SDF-1) is expressed. However, in terms of tu-
mor migration it appears unlikely that the metastatic niche of ES is
solely dependent on CXCL12 given that most ES metastasis locates to
the lungs but not other highly CXCL12-expressing tissues.
It has been shown that the chimeric protein EWS/FLI further modu-
lates the expression of genes that regulate the cytoskeleton. Cells affected
by the EWS/FLI expression exhibit a dramatic change in their cellu-
lar architecture. EWS/FLI reduces expression of zyxin and ↵5 integrin
which together leads to a loss of organized actin stress fibers and focal
adhesions, to a reduction of cell spreading, to an inhibition of cell mi-
gration, and to an enhanced growth-rate (Chaturvedi et al., 2012, 2014).
Moreover, expression of EWS/FLI causes a downregulation of haptotac-
tic cell migration in a Boyden chamber assay (Chaturvedi et al., 2012).
Knock-down of EWS/FLI as well as re-expression of zyxin and ↵5 in-
tegrin results in a partial recovery of the phenotype including a drastic
increase in cell adherence, and an increase in cell migration (Chaturvedi
et al., 2012, 2014). Hence, it appears likely that the EWS/FLI transloca-
tion in Ewing sarcoma leads, next to a chemotactic phenotype with high
CXCL12 sensitivity, to an altered mechanical phenotype that affects cell
adhesion, migration and more general cell mechanics.
Lately it has been demonstrated that the mechanical properties of the
cellular micro-environment, like its stiffness, can alter cellular behavior.
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Changes in micro-environment stiffness can alter cell growth, prolifera-
tion and spreading (Engler et al., 2006; Mierke, 2013; Park et al., 2011;
Paszek et al., 2005; Schrader et al., 2011; Wolf et al., 2013). Similarly,
in tumor environment variation of the physiological stiffness play a key
role in cancer cell migration (Liou et al., 2014; Mierke, 2013; Chaud-
huri et al., 2014) as well as chemotherapeutic response (Schrader et al.,
2011). Hence, research on mechanics of the tumor micro-envieronment
and tumor cells’ mechanosensing could lead to emerging of novel cancer
treatment strategies.
In the current study we address the relation between mechanical phe-
notypes and metastatic profiles of Ewing sarcoma cells. For this study
we chose two Ewing sarcoma cell lines, 6647 and CHP100, which dis-
play largely disparate metastatic behavior including their final metastatic
niche in lung and bone, respectively. We show that these two cell lines
exhibit markedly different mechanical phenotypes (spreading, migration
and force application) both in two- and three-dimensional assays. A
soft microenvironment induced an enhanced formation of stress fibers
and cell-matrix adhesions for 6647 cells, but not for CHP100 cells. Un-
like 6647 cells, CHP100 cells displayed a mechanical phenotype which
induce cellular forces with increased matrix stiffness. We were further
surprised to find that the activation of the CXCR4 receptor by its ligand
CXCL12 did not alter the phenotype or the mechanical response in ei-
ther of the cell lines. Our results suggest, that the mechanical properties
of the microenvironment are one of the key cues that dictate the choice
of metastasis site for Ewing sarcoma cells, while CXCL12 does not alter
the effect.
5.2 Materials and Methods
5.2.1 Cell culture and viral transfection
6647 (generously granted by T.J. Triche Lab) and CHP100 (EurBoNET
consortium collection (Ottaviano et al., 2010) ) cells were maintained in
IMDM cell culture medium (Gibco, USA) supplemented with 10% fetal
bovine serum (FBS, Gibco, USA) at 37 C and 5% CO2.
Where indicated, 6647 cells were transduced using a lentiviral
mCherry-LifeAct cDNA expression vector (provided by Olivier Pertz,
University of Basel, Switzerland) for visualization of the actin cytoskele-
ton. Cell selection was performed in a culture medium containing 2
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µg/mL puromycin (Acros Organics/Fisher).
5.2.2 Collagen gel assay
Collagen 3D migration experiments were performed and analysed as de-
scribed elsewhere (Balcioglu et al., 2015; Fig. 5.2A). Briefly, collagen
isolated from rat tails using acid extraction was diluted to final working
concentration in culture medium containing 0.1M Hepes and fixed to pH
7.5 by addition of NaHCO3. 60 µL of this solution was then pipetted
into a glass bottom 96-well plate (Greiner) and incubated 72 hours at
4 C, or for 1 hour at 37 C to polymerize. Subsequently, an automated
microinjector (Life Science Methods BV, Leiden, Netherlands) was used
to inject 3 spheroids of 60-75 µm radius, at 200 µm above the glass bot-
tom with an inter-spheroid distance of ⇠3.5 mm. Where indicated 100
nM CXCL12 was added to the medium after the injections. Spheroids
were imaged using a Nikon TE2000 confocal microscope equipped with
a Prior stage controlled by NIS Element Software (Nikon) and a temper-
ature and CO2-controlled incubator. Differential interference contrast
(DIC) images were captured with a CCD-camera. In house written Mat-
lab (Mathworks, Natick, MA, USA) scripts were used to perform image
analysis. Isolation of the injection core was achieved by intensity thresh-
olding. Canny edge detection was used to extract the injection outline
and single cells. Spheroid radius was calculated from the combined im-
age of injection core and injection outline. For single cell analysis, binary
image obtained by canny-edge filtering was watersheded to separate cell
clusters. Areas larger than 200 µm2 were considered as individual cells.
Due to irregular shape some cells were not included with such size thresh-
olding. For those a convex hull filter was applied to areas smaller than
200 µm2. The areas exhibiting sizes larger than 200 µm2 after convex
hull filtering were also included in the single-cells analysis. In single-cell
analysis the distance of each cell to the injection border was calculated
by subtracting the spheroid radius at day 0 from the distance of the cell
center to the injection center.
5.2.3 Micropillar preparation
Poly(dimethylsiloxane) (PDMS) micropillar arrays were prepared as de-
scribed before (van Hoorn et al., 2014). Briefly, silicon wafers (Bonda
thechnology PTE LDT) with a hexagonal-ordered negative pattern of 2
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Effective stiffness of the micropillar array surfaces of different hight
µm diameter holes and 2 µm spacing were used. PDMS (Sylgard 184,
Dow Corning) was mixed in a 10:1 ratio of base to crosslinker. The mix-
ture was degassed for 1 hour, poured over the master wafers and baked at
110 C for 20 hours. This preparation resulted in an elastomer of 2.5±0.1
MPa bulk stiffness (van Hoorn et al., 2014). The depth of the wafer holes
set the final height of the micropillars, and hence the micropillar spring
constant, and the effective stiffness of the micropillar array surface (Table
5.1). Micromicropillar arrays were flanked by 50 µm spacers to enable
upside-down imaging with a high-resolution microscope.
The top of the micropillar arrays were subsequently stamped with
fluorescencently-labeled fibronectin using micro-contact printing. A mix-
ture of 10 µg/mL Alexa 647 or 405 NHS-labeled fibronectin and 50
µg/mL non-labelad fibronectin (Sigma) was used. To prevent aspecific
binding, the micropillar surface was blocked with 0.2% pluronic F127
(Sigma) in phosphate buffered saline (PBS) for at least 30 minutes.
5.2.4 Microscopy
Brightfield microscopy and confocal imaging was performed as described
by van Hoorn et al. (van Hoorn et al., 2014). Briefly, images were ac-
quired using an Axiovert200 microscope (Zeiss, Germany) combined with
a spinning disk unit (CSU-X1, Yokogawa, Japan) and an emCCD cam-
era (iXon 897, Andor, UK). Imaging control and data acquisition was
achieved in IQ-software (Andor, UK). For illumination 405 nm (Crystal-
Laser), 514 nm (Cobolt), 561 nm (Cobolt) and 642 nm (SpectraPhysics)
lasers were used.
During imaging of live samples the CO2 level was maintained at 5%
and the temperature at 37 C using an INUBG2E-ZILCS unit (TokaiHit,
Japan). Where indicated, 100 nM CXCL12 was added to cells 10 minutes
prior to imaging.
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5.2.5 Force detection
Detection of micropillar deflections and following forces analysis was per-
formed using algorithms written in MatLab (Mathworks Inc., USA) as
described elsewhere (van Hoorn et al., 2014). Briefly, positions of the
micropillar tops were detected with a ⇠30 nm accuracy using fluorescent
images acquired at 642 or 405 nm excitation. Micropillar deflections were
extracted by referencing to a perfect hexagonal grid. Forces were ana-
lyzed for 300-900 micropillars per condition. Force-distributions were
calculated and subsequently analyzed in terms of their most probable
value and a standard error for the latter (Supplementary Fig. S4B).
5.2.6 Immunostaining
After overnight incubation on micropillars, cells were fixed with 4% PFA
in PBS for 15 min, and permeabilized using 0.1% TritonX in PBS. Sub-
sequently, cells were blocked with 1% BSA (Sigma, USA) for 1 hour.
Paxillin was detected using a monoclonal mouse-anti-human antibody
against paxillin (Invitrogen) and an Alexa405-labeled goat-anti-mouse
IgG antibody (Life Technologies). Actin staining was performed using
phalloidin conjugated to Alexa532 (Invitrogen).
5.2.7 Cell area detection
Cell area was determined using built-in ‘measurments’ plugins of FIJI
software. The cell edge was determined after background subtraction
and thresholding, followed by the tracing tool in FIJI. The results are
reported as mean±sem from 20-130 cells per condition.
5.2.8 2D migration rate detection
The 2D migration rate detection was acquired from brightfield images of
the cels. In each frame the center of mass of a cell was detected. From
acquired traces (Fig. 1E) mean square displacement of the cells was
calculated. Fit to a diffusion model (MSD=4Dt) yielded in D
migration
.
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5.3 Results
5.3.1 Cell phenotype depends on substrate modification
We investigated the Ewing sarcoma (ES) derived cell lines 6647 and
CHP100. Both cell lines were established in early 1970,s and later
identified as Ewing sarcoma by characteristic reciprocal translocation
t(11;22)(q24;q12) (Giovannini et al., 1994; Whang-Peng et al., 1986).
The 6647 cell line, established from a biopsy of a tumor that developed
in the femur, represents a prototypical Ewing sarcoma phenotype that
metastasizes into the lungs. In comparison, the metastatic niche of the
CHP100 cell line, which was derived from an epidural tumor surrounding
the spine, was bone (Schlesinger et al., 1976). Many ES cells, like 6647,
prefer to grow in tight connection forming spheroids in suspension (Lan-
duzzi et al., 2000). This was confirmed with our observations; 6647 cells
formed spheroids that were stable and span a range of sizes, 20-150 µm
in diameter containing 25-50000 cells. Cells mainly resided in suspension
with weak attachment to plastic substrates (Fig. 5.1A).
The suspension-phenotype of 6647 cells dramatically changed on the
dishes coated with extracellular matrix (ECM) proteins. When plated on
dishes, which were pre-coated with 0.1% gelatin (mainly collagen I), 6647
cells firmly adhered within a few hours. Individual cells spread out of
the spheroids over time invading the surface within 24 hours (Fig. 5.1B).
Cells that moved out of the spheroid exhibited a stretched, fibroblast-like,
morphology (Fig. 5.1B inset). Spread cells did not form new spheroids.
A similar behavior was observed for 6647 cells on surfaces coated with
10 µg/ml fibronectin (Fig. S1).
In contrast to 6647 cells, as was shown previously (Bernal et al.,
1983; Schlesinger et al., 1976) CHP100 cells grew as individual cells,
independent of the surface modifications (Fig. 5.1C,D). Cells did not
show any morphological differences while plated on plastic (Fig. 5.1C),
or on dishes coated with gelatin (Fig. 5.1D). Cells did not form spheroids,
neither in suspension nor on a surface. Individual cells firmly adhered to
surfaces and displayed a spread morphology (Fig. 5.1C, inset). Notably,
CHP100 cells did not exhibit any active migratory behavior (D
migration
= 75±2 µm2/h; Fig. 5.1E,F) within the 24 hours observation time.
These results showed that addition of ECM dramatically changes
morphology of the 6647 cells and their migratory abilities, while for the


































Ewing sarcoma cells growing at different conditions. 6647 cells growing on the plastic
petri dish (A) coated with gelatin/collagen I (B) followed for 24 hours after plating.
CHP100 cells growing on the plastic petri dish (C) pre-treated with gelatin/collagen
I (D) imaged after overnight incubation. Scale bar - 100 µm; time shown in hours;
inserts - 8 times zoom in. E. Migratory tracks of individual CHP100 cells. F. Change
of mean square displacement in time determined from shift of the center of mass of
individual cells.
























































































Microinjection of 6647 cells. A. Experiment scheme. Scale bar - 50 µm. Compar-
ison of number of the cells escaped from the spheroid (B and C) and the average
distance migrated by individual cells (D and E) at day 0-7 after injection in 0.5-2
mg/mL collagen gels polymerized at 37 C and after injection in 1 mg/mL collagen
gels polymerized at 4 C or 37 C, respectively. Data presented as mean ± standard
error.
our results on cell phenotype with respect to substrate modification il-
lustrate the difference in cell behavior that might be an early indicator
of the cell line dependent preference for metastatic niche.
5.3.2 Cell invasion in 3D is stiffness dependent
Given our finding that the chemical composition of the surface leads
to different cellular response of the two cell lines, we explored whether
and how the mechanical characteristics of the environment determined
their migratory phenotype. 3D migration assays in collagen gels were
performed on both 6647 and CHP100 cells. Gels with elastic modulus
up to 230 Pa (Paszek et al., 2005), were prepared. Cells were injected
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into gels and imaged 1, 2, 3, 4 and 7 days after injection. We used
0.5, 1 and 2 mg/mL collagens gels polymerized at 4 C or 37 C. Highly
concentrated cell suspension was injected into the gels creating spheroids
of 60-75 µm radius (Supplemental Fig. S2A). Time-laps DIC-images
were subsequently taken from those spheroids for further analysis.
Initially we analyzed the number of the cells that escaped from the
spheroids. Escaped cells were identified as described in Materials and
Methods section. The results of the analysis for 6647 cells are summa-
rized in Figure 5.2B-E. The number of escaped cells increased with time
and decreased with gel stiffness. Assuming a linear relationship during
the 7-days observation window, we found an escape rate of 21, 4, and 1
cells/day, for gels prepared from 0.5, 1 and 2 mg/mL collagen at 37 C,
respectively (Fig. 5.2B). It should be noted that changes in the concen-
tration of collagen not only results in a variation of the stiffness, but also
the gel microstructure, in particular its pore size differs (Raub et al.,
2007; Wolf et al., 2013) : the smaller the concentration of collagen the
bigger the pore size. Therefore, we created soft and stiff gels in which
the collagen concentration was kept constant (1 mg/ml). In this way the
collagen density was kept constant while the stiffness varied from soft to
stiff, at temperatures of 4 to 37 C respectively. Like in the experiments
in which the colagen concentration was varied, the initial escape rate
decreased in stiffer gels from 11 to 7 cells/day (Fig. 5.2C).
Further, we analyzed the migratory behavior of cells. We followed
the distance distribution of cells that escaped with respect to the initial
border of the spheroid in time. Data are shown for the mean distance
of escaped 6647 cells from 0 to 7 days after injection (Fig. 5.2D,E).
Next to the increased escape rate, cells exhibited an enhanced migratory
behavior in softer gels. We found that the mean distance increased linear
with time after injection, which suggests that cell migration was directed
in the outward direction and not governed by a diffusion. For the latter
one would predict that the mean squared-distances scale linear in time,
which contradicts our experimental findings (Fig. S2B,C). The drift
velocity was 36, 30, and 21 µm/day, for gels prepared at 37 C from 0.5,
1 and 2 mg/mL collagen, respectively (Fig. 5.2D). Our data suggest,
that the velocity of cell migration was primarily defined by the collagen
density. Accordingly, the initial drift velocity for gels that were prepared
at 4 and 37 C was similar - 38 and 41 mg/day, respectively (Fig. 5.2E),
implying that the increased number of escaped cells was not related to
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the cell migration velocity, but primary determined by probability to
detach from the spheroid, which was defined by the stiffness of the gel.
CHP100 cells showed a similar, yet overall reduced migratory behav-
ior with respect to gel stiffness and pore size (supplemental Fig. S3A-D).
Cells injected in 0.5 mg/mL collagen gels showed the largest rate of mi-
gratory cells of 16 cells/day (Fig. S3A), as well as the highest drift
velocity of 38 µm/day (Fig. S3C). Notably the drift velocity was similar
to that we found for 6647 cells. However, the onset of the migratory
behavior, which was prompt (within 1 day) for 6647 cells, was delayed
to ⇠2 days for CHP100 cells (compare Fig. 5.2B,C with Fig. S3A,B).
In summary, our results suggest that the mechanical properties of
the micro-environment modulates ES cell behavior. ES cells exhibit an
enhanced migratory behavior in soft micro-environments independent of
cell origin and metastatic niche. Likely this finding is a reflection of the
preference to the gel stiffness rather than the pore size of the gel.
5.3.3 Ewing sarcoma cells change their mechanical phe-
notype on micropillar arrays of varying stiffness
For further support of our hypothesis we analyzed the response of Ewing
sarcoma cells when the stiffness of the microenvironment was varied in
a more controlled manner. We used elastomeric micropillar arrays of
various heights to change the substrate stiffness without changing the
chemistry, the network properties or the topology of the substrate (Tan
et al., 2003). Micropillars of 2 µm diameter and heights of 3.2, 4.1 and
10 µm, corresponding to an effective array stiffness of 137.1, 47.2 and
7.5 kPa, were produced from poly(dimethylsiloxane). The micropillar
arrays were stamped with fluorescencently-labeled Alexa647-conjugated
fibronectin to enable visualization of the micropillars, and to allow cells
to form specific adhesions on the micropillar tops. Cells plated onto
the micropillars were incubated overnight, followed by cell fixation and
immunostaining for paxillin and F-actin (Fig. 5.3A for 6647 cells, and
Supplemental Fig. S4 for CHP100 cells).
For both cell lines we found a behavior that could be predicted
from their behaviour on continuous substrates. 6647 cells grown on
stiff, 47.2 and 137.1 kPa, micropillar arrays were small, areas of 300±20
and 310±15 µm2 (Fig. 5.3A,B), and only weakly adherent. However,
when grown on soft, 7.5 kPa, micropillar arrays, 6647 cells presented a
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Ewing sarcoma cells on micropillars. A. Confocal images of the 6647 cells placed on
the micropillars of various stiffness. Pseudo colors represent fibronectin/micropillar
tops (red), actin (green) and paxillin (blue). The scale bar - 10 µm; force scale bar
(arrow) - 20 nN, if not indicated otherwise. B. Average cell area detected for CHP100
and 6647 cells. C. Maximum probable forces determined for CHP100 and 6647 cells
on the micropillars of different stiffness.
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to 470±20 µm2 (Fig. 5.3B). On stiff substrates, the morphological phe-
notypes were paralleled by the inability to form cell-matrix adhesions
(no paxillin recruitment, Fig. 5.3A) and the inability to apply forces
(Fig. 5.3A,C). On soft, 7.5 kPa, substrates paxillin was recruited to
elongated patches characteristic for cell-matrix adhesions (Fig. 5.3A),
and cells applied a mean force of 1.5±0.4 nN to individual micropillars
(Fig. 5.3A,C).
The morphology (Fig. S4) and cell area (900±50, 760±50 and 850±40
µm2) was independent of substrate stiffness (137.1, 47.2 and 7.5 kPa, re-
spectively) for CHP100 cells (Fig. 5.3B). On substrates of all stiffnesses,
paxillin was recruited to form clearly developed cell-matrix adhesions
coupled to actin stress fibers (Fig. S4A). Forces increased with sub-
strate stiffness (Fig. S4B and Fig. 5.3C). The force distributions shown
in Fig. 5.3C were characterized by their most probable force for indi-
vidual micropillars of 2.0±0.4, 5.6±0.8 and 10.7±1.1 nN for substrate
stiffness of 7.5, 47.2 and 137.1 kPa, respectively (Fig. S4B). Hence, al-
though the morphological phenotype of CHP100 cells was unchanged, a
mechanical phenotype developed in which the cellular forces increased
with the stiffness of the substrate. Such behavior has been reported for
various cell types including fibroblasts (Balcioglu et al., 2015).
Taken together our results confirm the hypothesis that the two cell
lines develop into mechanically divergent phenotypes, which react on the
mechanical properties of their environment. Whereas 6647 cells favored
soft surfaces CHP100 cells showed no preference, however reacted on
stiffer substrates with higher forces.
5.3.4 Dynamic force development depends on substrate
stiffness
We further characterized the dynamics of force built-up and release in a
live-cell setting. For visualization we stably transfected 6647 cells with
LifeAct-mCherry (further referred to as 6647-mCherry), which allowed
us to image the dynamics of the actin network. Similar to the fixed-
cell experiments, micropillars were fluorescently labeled with Alexa405-
conjugated fibronectin to allow for the force readout. Cells were incu-
bated overnight on soft (7.5 kPa) and stiff (137.1 kPa) micropillar arrays.
On the stiff arrays approximately 50% of the 6647-mCherry spheroids ad-
hered to the micropillar surface (data not shown). Only very few cells
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Figure 5.4
Life imaging of 6647-mCherry cells on the micropillars. A. Confocal image of the
6647-mCherry cells on 137.1 kPa micropillars after overnight incubation. Pseudo
colors correspond to fibronectin/micropillar tops (blue) and actin (red). B. Cell
area determined at micropillars of different stiffness. C. 6647-mCherry on 7.5 kPa
micropillars. D. Time trace of the forces applied to individual micropillars (pink,
blue and green) and control micropillars (grey). The scale bar - 10 µm; force scale
bar (arrow) - 20 nN.
in terms of single-cell and single-micropillar forces. The slight differences
in morphology when compared to the results on fixed cells presumably
reflect fixation artefacts: the morphology of the cells appeared more
spread with a mean cell area of 500±35 (compare Fig. 5.3B with Fig.
5.4B). As in the fixed-cell setting 6647-mCherry cells did not exert any
detectable forces (Fig. 5.4A), even no short transients, which could have
been overlooked in the fixed cell setting.
On soft micropillar arrays the live-cell experiments also confirmed our
findings on fixed cells. For individual cells which spread out from the
initial spheroids, the cell morphology was significantly larger when com-
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pared to hard substrates with a mean cell area of 670±30 µm2. Spread
cells applied mean forces of 2.1±0.4 nN on individual micropillars (Fig.
5.5D). The increase in force from 1.5 to 2.1 nN when compared to fixed
cells is an observation that has been reported earlier and attributed to
cell fixation (Balcioglu et al., 2015). The live-cell setting subsequently
allowed us to directly observe the built-up and release of cellular forces.
Force built-up and release was observed to occur on a similar timescale
characterized by a rate of 0.4±0.2 nN/min and a typical half time of
t1/2= 4.2±0.3 min. This timescale was comparable to that we earlier
found for a fibroblast cell line of t1/2 ⇡3 minutes (not published). Pre-
sumably this implies that initiation of ES cells migration is similar to
that found for cell motility of fibroblasts.
5.3.5 Activation of cells did not alter their morphological
and mechanical phenotype
Many cancer cells, including Ewing sarcoma, are characterized by a sig-
nificant overexpression of the chemokine receptor CXCR4. Overexpres-
sion of CXCR4 was found to be strongly correlated with the metas-
tastatic state and invasiveness of cells (Bennani-Baiti et al., 2010). Both
cell lines, 6647 and CHP100, investigated here, were reported for their
high expression level of CXCR4 (Sand et al., in print). Hence, we ad-
dressed the hypothesis whether stimulation of CXCR4 would result in
higher motility and potentially associated increased force phenotype.
Migration of 6647 cells in 1 mg/mL collagen gels that were polymer-
ized at either 4 C or 37 C did not show any significant difference in the
number of cells which escaped from the spheroid for global stimulation
with 100 nM CXCL12 (Fig. 5.5A). This finding suggested that activation
of CXCR4 did not induce enhanced cell migration. The result for 3D
gels was in agreement with our experiments on Ewing sarcoma cells on
2D substrates (data not shown), but in contrast to other findings which
indicated that CXCR4 overexpression enhanced 2D migratory behavior
of ES cells (Jin et al., 2012; Krook et al., 2014). Further, we did not
observe any significant change in the force application neither on stiff
(137.1 kPa, Fig. 5.5B) nor on soft (7.5 kPa) micropillars (Fig. 5.5C,D),
respectively.
Hence, activation of the CXCR4 receptor did not alternate the re-
sponse of ES cells on the stiffness of their micro-environment, at least































































Influence of CXCR4 activation on 6647 response to the stiffness. A. Comparison
of the number of the cells escaped from the spheroid at day 3 after injection in 1
µg/mL collagen gels polymerized at 4 C or 37 C with and without CXCL12 in the
medium. B. Confocal image of the 6647-mCherry cells on 137.1 kPa micropillars 15
minutes after CXCL12 addition. Pseudo colors correspond to fibronectin/micropillar
tops (blue) and actin (red). The scale bar - 10 µm; force scale bar (arrow) - 20
nN. C. Time trace of the forces applied by 6647-mCherry cells to individual 7.5
kPa micropillars (purple) and control micropillars (grey) before and after CXCL12
stimulation. D. Maximum probable forces determined on the 7.5 kPa micropillars
under different conditions.
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mechanosensing and response to micro-environment stiffness is not cor-
related with CXCR4 signaling in ES cells.
5.4 Discussion
Ewing sarcoma is a cancer, which develops in bone and soft tissue. The
cell of origin for Ewing sarcoma is so-far unknown (Ludwig, 2008). There
is however evidence indicating that Ewing sarcoma derives from cells
determined to become neuronal or pluripotent cells that show blocked
differentiation (Kovar, 2005). Some cell lines established from primary
tumors were initially characterized as neuroblastoma (Bernal et al., 1983;
Schlesinger et al., 1976) or rhabdomyosarcoma (Giard et al., 1973; Marti-
nez-Ramirez et al., 2003), but later characterized as Ewing sarcoma
by analysis for the EWS/FLI expression (Giard et al., 1973; Martinez-
Ramirez et al., 2003). The Ewing sarcoma develops in the bone, and the
primary site of metastasis are the lungs, with other metastatic niches
have been found to be the bone and bone marrow. Hence, the microen-
vironment of the primary tumor (stiffness 100 kPa; Engler et al., 2006;
Moore et al., 2010 ) is significantly more stiff than that of the metastasis
site (⇠2 kPa for lungs; Booth et al., 2012). This observation spurred our
investigation, to identify a potential role of mechanosensing in Ewing
sarcoma metastasis. We hypothesized that mechanical cues could lead
to guidance of Ewing sarcoma cells towards their site of metastasis. A
similar modulation of the cellular mechanical phenotype was achieved
via alternation of the substrate stiffness for other cell types (Engler et
al., 2006). Our hypothesis was supported by reports that adhesion of
the Ewing sarcoma cells is largely modulated by the chimeric protein
EWS/FLI. EWS/FLI expression was found to cause a loss of organized
actin stress fibers, focal adhesion and cell spreading (Chaturvedi et al.,
2012, 2014).
In order to find a correlation between mechanical phenotype and
metastatic niche of Ewing sarcoma cells we compared cells derived from
patients with metastasis localized in lungs (6647) or in bone (CHP100).
These two cell lines showed a significant difference in response to changes
in the mechanical properties of their microenvironment both in 2D and
3D. 6647 cells, showed a clear preference to softer substrate. Similar to
other ES cells (Kodama et al., 1991) 6647 migrated best in soft sub-
strates. Furthermore, 6647 cells exhibited a different cell morphology on
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the softer substrate: cells were more spread and showed indications of
paxillin recruitment as well as actin stress fiber formation, all indicators
of stronger cell adherence. Remarkably, such alteration in cell morphol-
ogy on the soft substrates is in contrast with findings for fibroblasts and
other cell lines, which spread significantly better on stiff as compared to
soft gels (Paszek et al., 2005). Likewise, 6647 cells showed force applica-
tion only when placed on softest substrate, while many other cell lines,
including CHP100, exhibit increased contractile forces when cultured on
stiffer matrices. Additionally, in contrast to 6647, CHP100 cells did not
show any strong substrate-stiffness dependence in their morphological or
migratory behavior. Hence, our results point to a correlation between
cellular response to the substrate stiffness and Ewing sarcoma metastasis
localization. Thereby, suggesting that Ewing sarcoma cells could be fol-
lowing a mechanical cue when choosing the site for metastasis formation.
Taken that both cell lines showed reduced migration in stiffer 3D gels,
one could argue that lack of migration of ES cells in stiff microenviron-
ment would severely obstruct their escape into the blood stream as an
initial step in metastatic development. However, following Chaturvedi
et al. due to the tumor localization Ewing sarcoma cells have an easy
access to the intravascular space and do not need active cell migration
(Chaturvedi et al., 2012). It is tempting to speculate on the further
mechanism of ES metastasis. Taken that both, our results and findings
of other groups, showed anchorage-independent growth of ES cells (Lan-
duzzi et al., 2000), in the blood stream individual cells would probably
further form spheroids. Spheroids would be easily transported through
the body, eventually acquiring a critical size that would jam in the small-
est capillaries. Further, as our data suggest that, 6647 cells would only
escape the speroid in soft tissue, e.g lungs (⇠2 kPa), but not in stiff
tissues like kidney (⇠4 kPa; Bensamoun et al., 2011) or bone ( 100 kPa).
Thus, for 6647 cells lungs are the preferential site for metastasis. In
contrast, CHP100 cells which do not change migratory phenotype with
substrate stiffness, but increase their force application and concomitantly
strengthen their adhesion with increasing stiffness, would suggest their
tendency to metastasise into the hardest environments of the body, i.e.
bone.
In summary, our results point out that the mechanical properties of
the microenvironment does modulate Ewing sarcoma cell morphology
and mechanical phenotype. Our model imply that mechanosensing is
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potentially one of key regulators during Ewing sarcoma metastasis and
has a great impact on directing cells to their specific metastasis site.
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5.5 Supplemental figures
Figure S1
6647 cells growing on the plastic petri dish coated with fibronectin followed for 24
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Comparison of the injected spheroids at day 0 A.and the average square displace-
ment of individual 6647 B. and CHP100 C. cells at day 0-7 after injection in 0.5-2
mg/mL collagen gels polymerized at 37 C and after injection in 1 mg/mL collagen
gels polymerized at 4 C or 37 C, respectively.



















































































Comparison of the number of the cells escaped from the spheroid (A and B) and the
average distance migrated by individual cells (C and D) at day 0-7 after injection
in 0.5-2 mg/mL collagen gels polymerized at 37 C and after injection in 1 mg/mL
collagen gels polymerized at 4 C or 37 C, respectively.
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CHP100 cells on micropillars. A. Confocal images of the CHP100 cells placed on
the micropillars of various stiffness. Pseudo colors represent febronectin/micropillar
tops (red), actin (green) and paxillin (blue). The scale bar - 10 µm; force scale bar
(arrow) - 20 nN, if not indicated otherwise. B. Distribution of the probability density
of the forces detected for CHP100 cells on micropillars of various stiffness.
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Summary
The first description of cancer dates back to the ancient Papyrus Ebers
in 1500 B. C. The term ’metastasis’, the uncontrolled cell growth at
distant sites, was first introduced by Lobstein in the beginning of 19th
century. In 1889 Stephen Paget suggested a predisposition for sites of
metastasis based on 735 fatal cases of breast cancer in multiple reports.
He introduced the ’seed and soil’ concept, where ’seeds’ are the cancer
cells with metastatic capacities, and ’soil’ is the tissue or organ providing
the proper microenvironment for growth. To date this concept is widely
accepted with a stunning amount of molecular insights, which have led
to a better understanding of both the ’seed’ and the ’soil’.
Ewing sarcoma, discovered in 1921, is a neoplasm in the bone, which
forms metastasis even at an early stage of tumor development. The de-
velopment of metastasis is correlated with poor patient prognosis and,
hence, low long-term survival rate. Interestingly, Ewing sarcoma metas-
tasis exhibits a well-defined distribution along the body. Ewing sar-
coma metastasis is predominantly restricted to the lungs, followed by
bone/bone marrow localization. In some cases simultaneous combined
lung/bone/bone marrow metastasis localization have been reported.
Metastatic sites in other locations rarely occur. As such, the microen-
vironment of Ewing sarcoma metastasis can be either that of the pri-
mary tumor (bone) or it can be drastically different (lung). Hence, the
consistency of Ewing sarcoma metastasis localization implies a cellular
predisposition.
Many studies attempted to obtain an understanding of the mech-
anism underpinning the metastatic behavior of Ewing sarcoma. The
metastatic capacity was found to be correlated with the expression of
the chemokine receptor CXCR6, the G-protein coupled receptor GPR64,
increased level of interleukin 6, Caveolin 1, IGF-1R and an enhanced ac-
tivity of the metalloproteinases 2 and 9. A special role was attributed
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to the chemokine receptor CXCR4, which is overexpressed in metastatic
Ewing sarcoma, and is regulated by the Ewing sarcoma-specific fusion
protein EWS/FLI1. EWS/FLI1 was previously shown to modulate the
architecture and integrity of the cytoskeleton, which is viewed as further
prerequisite for ES metastasis. Although a significant amount of data
is available, a comprehensive model of Ewing sarcoma metastasis is yet
to be developed. In this thesis the biochemical and biophysical factors
involved in Ewing sarcoma metastasis are further explored.
In Chapter 2 a single-molecule imaging technique was applied to
examine the dynamics of the chemokine receptor CXCR4 on the plasma
membrane of an Ewing sarcoma-derived cell line (A673). The CXCR4
mobility on the plasma membrane was detected at 30 nm positional accu-
racy and 50 ms temporal resolution. This temporal and positional resolu-
tion enabled distinguishing different mobility fractions/states of CXCR4
and following the transition between the mobile and immobile state of
the receptor upon different conditions. Immobilization of CXCR4 oc-
curred upon stimulation with its ligand CXCL12 in a concentration-
dependent manner. The receptors’ mobility change during activation
appeared to be dependent on its signaling both through G-protein depen-
dent and independent pathways. Signaling through G-proteins resulted
in CXCR4 immobilization potentially into a supramolecular scaffold (sig-
nalosome), which could then enhance signaling. In contrast, activation of
the G-protein independent pathway caused receptor immobilization into
clathrin-coated vesicles leading to its internalization and, thus, receptor
desensitization. As signaling through G-proteins appeared to interfere
with receptor endocytosis, the findings of this study indicate a functional
cross-talk between different biochemical cascades.
The involvement of G-protein activation in regulation of CXCR4 was
further addressed in the study described in Chapter 3. The dynamics
of two G
↵




exhibited a fast response on activation of CXCR4 by the formation of
cluster-like structures. Single-molecule imaging revealed that the two
G
↵
subunits follow a different coupling mode with the receptor. G
↵q
appeared pre-coupled to the receptor and exhibited uncoupling upon re-
ceptor activation. In contrast, G
↵i
was not coupled to CXCR4 prior
to receptor activation and exhibited elevated coupling with the recep-





suggested a sequential coupling of the G-proteins to
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CXCR4. This finding is in agreement with experiments that analyze the




to initiate downstream cascades. Taken
that signaling through G
↵q
is a prerequisite for enhanced G
↵i
signaling,
the ability of CXCR4 to subsequently activate both G
↵
subunits might
act as a receptor signaling regulatory mechanism.
In Chapter 4 the development of a light-activated chimeric receptor,
usable for high temporally and spatially resolved activation and detection
was described. The base construct was developed by exchange of the in-
tracellular loops and C-terminus of the light-activated GPCR, rhodopsin,
with the intracellular loops and the C-terminus of the chemokine receptor
CXCR4. The cloning steps resulted in a chimeric receptor, optoCXCR4,
which presumably was able to initiate CXCR4-specific signaling cascades
by light-activation. The optoCXCR4 was further modified on both N-
and C-terminals. All the constructs were tested for plasma membrane lo-
calization and functionality properties. A successful construct represent-
ing a promising tool for further biophysical investigation of chemokine
receptor CXCR4 was developed. A key to proper functionality of the con-
struct was the correct light-protection settings during all experimental
procedures. The applicability of this promising approach in optogenetics
was further discussed.
The involvement of the stiffness of the micro-environment in Ewing
sarcoma metastasis was addressed in the study described in Chapter
5. The development of Ewing sarcoma in bones with metastasis sites
to either bones or lungs, suggested the existence of a mechanical cue
for Ewing sarcoma metastasis. This hypothesis was tested using Ewing
sarcoma-derived cell lines, which preferred a largely disparate metastatic
niche of bone (CHP100) and lungs (6647). In 2D and 3D assays 6647
cells exhibited a strong preference towards the mechanically soft micro-
environment. Only on soft substrates 6647 cells were able to develop
adhesions and developed an organized actin cytoskeleton. In contrast,
CHP100 cells exhibited a higher adhesion potential on stiff substrates.
Thus, the mechanical properties of the micro-environment caused a dif-
ferential behavior of Ewing sarcoma cells of different metastatic profile.
It was further evident that this mechanical phenotype was independent
of CXCR4 receptor activation.
Taken together, the results presented in this thesis provide deeper
insights into the mechanisms controlling signaling of the chemokine re-
ceptor CXCR4 and into the role of the micro-environment in Ewing sar-
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coma cells behavior. Through various experimental approaches it was
shown that both biochemical and biophysical guidance control how Ew-
ing sarcoma develops into its distinct metastatic phenotype.
Samenvatting
De eerste omschrijving van kanker dateert uit het eeuwenoude Ebers
Papyrus uit 1500 BC. De term ‘metastase’, ongecontroleerde groei van
cellen op ver afgelegen locaties, werd voor het eerst geïntroduceerd door
Lobstein in het begin van de 19e eeuw. Stephen Paget suggereerde in
1889 een aanleg voor metastase gebaseerd op 735 dodelijke gevallen van
borstkanker in verscheidene verslagleggingen. Hij introduceerde het con-
cept van ‘zaad en voedingsbodem’, waarbij ‘zaden’ de kankercellen zijn
die metastatische capaciteit hebben en de ‘voedingsbodem’ het weefsel of
orgaan aanduidt dat de micro-omgeving voor groei geeft. Tot op heden
is dit concept wijdverspreid geaccepteerd met een indrukwekkende hoe-
veelheid aan moleculaire inzichten, welke hebben geleid tot een beter
begrip van zowel de ‘zaden’ als de ‘voedingsbodem’.
Ewing sarcoma, ontdekt in 1921, is een neoplasme in het bot, welke
metastase vertoont op een vroeg tijdstip van de tumorontwikkeling. De
ontwikkeling van metastase is gerelateerd aan een slechte prognose voor
de patiënt en dus een lage overlevingskans op de lange termijn. Op-
merkelijk is dat Ewing sarcoma metastase een goedgedefinieerde verde-
ling vertoont in het lichaam. Ewing sarcoma metastase is voornamelijk
beperkt tot de longen, gevolgd door bot/beenmerg lokalisatie. In som-
mige gevallen wordt gelijktijdige long/bot/beenmerg metastase lokalisatie
gerapporteerd. Metastase op andere locaties zijn zeldzaam. Zodoende
kan de micro-omgeving van Ewing sarcoma metastase ofwel van de pri-
maire tumor (bot) of heel erg verschillend (long) zijn. De consistentie
van Ewing sarcoma lokalisatie impliceert daarmee een specifieke cellu-
laire voorkeur.
Vele studies probeerden het mechanisme achter het metastatisch
gedrag van Ewing sarcoma te begrijpen. De metastatische aanleg bleek
gecorreleerd te zijn met de expressie van de chemokine receptor CXCR6,
de G-eiwit gekoppelde receptor GPR64, verhoogd niveau van interleukin
146 Samenvatting
6, Caveolin 1, IGF-1R en een verhoogde activiteit van metalloproteinases
2 en 9. Een bijzondere rol werd toegekend aan de chemokine recep-
tor CXCR4, welke tot overexpressie kwam in metastatische Ewing sar-
coma, en is gereguleerd door het Ewing sarcoma-specifieke fusie-eiwit
EWS/FLI1. Het was eerder aangetoond dat EWS/FLI1 de architectuur
en integriteit van het cytoskelet moduleert, wat wordt gezien als een
verdere voorwaarde voor Ewing sarcoma metastase. Hoewel een signif-
icante hoeveelheid data beschikbaar is, is een volledig model van Ew-
ing sarcoma metastase nog niet ontwikkeld. In dit proefschrift worden
de biochemische en biofysische factoren betrokken bij Ewing sarcoma
metastase verder verkend.
In Hoofdstuk 2 werd microscopie van enkele moleculen toegepast
om de dynamische eigenschappen van chemokine receptor CXCR4 op het
plasmamembraan van een Ewing sarcoma cellijn (A673) te onderzoeken.
De mobiliteit van CXCR4 op het plasmamembraan werd gedetecteerd
met 30 nm positienauwkeurigheid en 50 ms tijdsresolutie. Deze tijds- en
positieresolutie maakte het mogelijk om verschillende fracties/toestanden
van de mobiliteit van CXCR4 te onderscheiden en transities tussen mo-
biele en immobiele toe-standen van de receptor onder verschillende toe-
standen te volgen. Immobilisatie van CXCR4 vond plaats wanneer sti-
mulatie met de ligand CXCL12 werd toegediend afhankelijk van de con-
centratie. De verandering van mobiliteit van de receptoren gedurende
activatie leek afhankelijk te zijn van zowel signalen door G-eiwit afhanke-
lijke en onafhankelijke cascades. Signalen via G-eiwitten resulteerden in
CXCR4-immobilisatie mogelijk door een supramoleculair schavot (sig-
nalosoom), welke dan het signaal zou kunnen versterken. Activatie van
de G-eiwit onafhankelijke cascade, daarentegen, veroorzaakte immobi-
lisatie van de receptor in clathrin-bedekte blaasjes welke geïnternaliseerd
werden met minder gevoeligheid voor de receptor als gevolg. Aangezien
signalen door G-eiwitten belemmerd leken te worden door endocytose
van receptoren, geven de resultaten van deze studie aan dat er een func-
tionele overspraak is tussen verschillende biochemische cascades.
De betrokkenheid van G-eiwit activatie in de regulatie van CXCR4
werd verder geadresseerd in de studie die wordt beschreven in Hoofd-
stuk 3. De dynamica van twee G
↵





toonden een snelle respons op activatie van
CXCR4 door de vorming van clusterachtige structuren. Enkel-molecuul
beeldvorming openbaarde dat de twee G
↵
subunits een verschillende kop-
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pelingsmodus volgen met de receptor. G
↵q
leek al vooraf gekoppeld aan
de receptor en toonde ontkoppeling wanneer de receptor activeerde. G
↵i
,
daarentegen, was niet gekoppeld aan CXCR4 voor receptor activatie en
toonde toegenomen koppeling met de receptor wanneer er werd gesti-





suggereerde een sequentiële koppeling van de G-eiwitten aan
CXCR4. Deze bevinding is in overeenkomst met de experimenten die de




om verdere cascades te
initiëren. Gezien signalen via G
↵q
een vereiste zijn voor versterkte G
↵i
signalen is het vermogen van CXCR4 om beide G
↵
subunits te activeren
wellicht een regulerend mechanisme voor het signaal van de receptor.
In Hoofdstuk 4 wordt de ontwikkeling van een licht-geactiveerde
chimerische receptor omschreven, inzetbaar voor activatie en detectie
met hoge tijds- en positieresolutie. Het basisconstruct werd ontwikkeld
door de uitwisseling van de intracellulaire lussen van de licht-geactiveerde
GPCR rhodopsin met de intracellulaire lussen en het C-uiteinde van
de chemokine receptor CXCR4. De kloonstappen resulteerden in een
chimerische receptor, optoCXCR4, welke vermoedelijk CXCR4-specifieke
signaalcascades kon initiëren door middel van licht-activatie. De opto-
CXCR4 werd verder aangepast op zowel de N- als de C-uiteinden. Alle
constructen werden getest op lokalisatie aan het plasmamembraan en op
functionele eigenschappen. Een succesvol construct dat een veelbelovend
werktuig voor verdere biofysische onderzoeken van chemoking receptor
CXCR4 is werd ontwikkeld. Cruciaal voor de juiste functionaliteit van
het construct was de correcte licht-beschermingsomstandigheden tijdens
de experimentele procedures. De toepasbaarheid van deze veelbelovende
aanpak in optogenetica werd verder bediscussieerd.
De afhankelijkheid van de stijfheid van de micro-omgeving van Ewing
sarcoma metastase werd geadresseerd in de studie beschreven in Hoofd-
stuk 5. De ontwikkeling van Ewing sarcoma in botten met metastase
naar ofwel bot of longen suggereerde een mogelijke mechanische invloed
voor Ewing sarcoma metastase. Deze hypothese werd onderzocht met
Ewing sarcoma-afgeleide cellijnen, welke de voorkeur toonden voor ver
uiteen gelegen niches van bot (CHP100) en longen (6647). In 2D en
3D assays toonden 6647 cellen een sterke voorkeur voor een mecha-
nisch zachte micro-omgeving. 6647 cellen konden alleen op zachte sub-
straten aanhechtingen vormen en ontwikkelden een georganiseerd actine
cytoskelet. CHP100 cellen, daarentegen, hechtten zich beter aan stij-
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vere substraten. De mechanische eigenschappen van de micro-omgeving
veroorzaakten dus een verschil in gedrag van Ewing sarcoma cellen uit
een verschillend metastatisch profiel. Bovendien werd het duidelijk dat
dit mechanische phenotype onafhankelijk was van CXCR4 receptor ac-
tivatie.
De resultaten in dit proefschrift geven tezamen een dieper inzicht
in de mechanismes achter zowel de signalen van CXCR4 als de micro-
omgeving respons waarin cellulair gedrag van Ewing sarcoma cellen wor-
den bepaald. Door verschillende experimentele methodes is aangetoond
dat zowel biochemische als biofysische geleiding bepalen hoe Ewing sar-
coma ontwikkelt naar een specifiek metastatisch phenotype.
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